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Abstract 1 
 
Abstract 
Synaptic plasticity and stability are the most important mechanisms in the brain for establishing 
memory processes. Neural networks are constantly changing to transform newly learned 
knowledge into synaptic connections and strengthen existing connections. Especially the 
hippocampus is the region for memory consolidation. Thus, a high-frequency activation of CA1 
neurons in the hippocampus lead to an amplification of existing synaptic contacts, also known 
as long-term potentiation (LTP), whereas low frequency stimulation leads to weakening of 
synaptic contacts, long-term depression (LTD). Synaptic processes are particularly vulnerable 
with age to various internal molecules as well as environmental factors. Many of these 
molecules are already well researched but the mechanisms behind are still unclear. For example, 
an application of APPsα a cleavage product of the amyloidogenic precursor protein (APP) leads 
to a physiological LTP in mouse models of Alzheimer's disease (Hick et al., 2015), but the receptor 
remains unknown. In this study, I was able to identify a potential receptor. Another important 
role in terms of altered synaptic plasticity during age play inflammatory processes. They have 
remained unexplored for a long time but over the last few decades they gained more 
importance. As the age limit in today's society is steadily increasing and inflammatory processes 
occur especially with age, there must be more effort towards inflammatory research. In this 
study, I was able to show a positive age- and gender-dependent role of the knockout (KO) of the 
NALP3 inflammasome, localized in microglia cells, the macrophages of the brain. Aged female 
NLRP3 KO animals show an increased LTP compared to age-matched males and wildtype 
animals. In addition, experiments on human autoimmune antibodies (AAB) were also conducted 
in this thesis. I was able to show that the long-term application of human AAB leads to reduced 
LTP and lower spine density in the hippocampus. These results are epitope specific, as different 
patients suffering from different autoimmune diseases show different results.  
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Zusammenfassung 
Synaptische Plastizität und Stabilität sind die wichtigsten Mechanismen im Gehirn für die 
Etablierung von Gedächtnisprozessen. Neuronale Netzwerke befinden sich im ständigen 
Wandel, um neu erlernte Kenntnisse in synaptische Verknüpfungen umzuwandeln und 
bestehende Verknüpfungen zu verstärken. Vor allem der Hippokampus ist die Region für 
Gedächtnis-Konsolidierung. So führt eine hochfrequente Aktivierung von CA1 Neuronen im 
Hippokampus zu einer Verstärkung von bestehenden synaptischen Kontakten, auch bekannt als 
Langzeitpotenzierung (LTP), wohingegen eine niederfrequente Stimulation zur Abschwächung 
der synaptischen Kontakte führt, auch Langzeitdepression (LTD) genannt.  Synaptische Prozesse 
sind vor allem mit dem Alter angreifbar gegenüber verschiedensten körpereigenen Molekülen 
sowie Umweltfaktoren. Viele dieser Moleküle sind bereits gut erforscht doch die 
Wirkungsmechanismen sind immer noch unklar. So führt eine Zugabe von APPsα, einem 
Spaltprodukt des amyloidogenen Vorläuferproteins (APP) zu einem physiologischen LTP in 
Mausmodellen der Alzheimer Krankheit (Hick et al., 2015), doch der Rezeptor bleibt unbekannt. 
In dieser Arbeit konnte ich einen Rezeptor identifizieren. Eine weitere wichtige Bedeutung in 
Bezug auf veränderte synaptische Plastizität während des Alters kommt den inflammatorischen 
Prozessen zu. Diese sind im Laufe der letzten Jahrzehnte immer mehr in den Vordergrund 
gerückt und blieben lange Zeit unerforscht. Da die Altershöchstgrenze in der heutigen 
Gesellschaft stetig steigt und inflammatorische Prozesse vor allem mit dem Alter auftreten muss 
ihnen mehr Bedeutung zugestanden werden. In dieser Studie konnte ich eine positive alters- 
und geschlechtsabhängige Rolle des knockouts (KO) des NALP3 Inflammasomes, lokalisiert in 
Mikrogliazellen, den Makrophagen des Gehirns, zeigen. Gealterte, weibliche NLRP3 KO Tiere 
zeigen ein gesteigertes LTP gegenüber altersgleichen Männchen und Wildtyp-Tieren. Zudem 
wurden in dieser Arbeit auch Experimente bezüglich humaner Autoimmunantikörper (AAK) 
durchgeführt. Ich konnte zeigen, dass die Langzeitzugabe von humanen AAKs zu einer 
verringerten Langzeitpotenzierung und zu einer geringeren Dichte von Dornfortsätzen, den 
postsynaptischen Endigungen im Hippokampus, führt. Dieses Ergebnis ist zudem Epitop-
abhängig, da die verschiedenen Patienten, die an verschiedenen Autoimmunerkrankungen 
leiden, verschiedene Resultate zeigten. 
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“As long as our brain is a mystery, the 
universe, the reflection of the structure of the 
brain will also be a mystery.”  
   - Santiago Ramón y Cajal - 
1. Introduction 
The brain is a very complex organ with millions of neurons, dendrites and synapses that form 
contacts to spread information through the brain. It is in constant balance between stability and 
plasticity to create new synapses and strengthen existing neuronal connections. These activity-
dependent functional and structural changes at synapses are called synaptic plasticity and are 
fundamentally important for learning and memory formation occurring especially in the 
hippocampus. The ability to learn and store memory can be influenced by mental disorders like 
Alzheimer’s disease where the balance of stability and plasticity is shifted to one or another 
direction. Systemic innate immune activation has been identified as risk factor for Alzheimer´s 
disease in humans as a kind of inflammation. Inflammatory processes occur on the one hand 
with age and on the other hand through external influences and can differ between sexes. 
Especially autoinflammatory processes have gained in importance in research in the last decades 
as they can lead as well to a balance shift in the brain and therefore to cognitive diseases. 
This thesis focuses on the connection between cognitive impairments like Alzheimer’s disease 
and autoinflammatory pathways in terms of synaptic plasticity in the hippocampus. Another 
part focuses on sex dependent differences in an inflammatory pathway during age. 
 
1.1 Synaptic plasticity 
It is very impressive, that neuronal cells in the mammalian brain can change their connectivity, 
structure and functionality in response to activity. This process is called synaptic plasticity. The 
neuroanatomist Santiago Ramon y Cajal was hypothesizing that plasticity in the brain can be 
described as the generation of new contacts between cortical neurons which is essential for the 
persistence of memory (Cajal, 1894). The plasticity occurs on a structural level (structural 
plasticity) and is defined by the number and strength of synaptic contacts, as well as on the 
molecular level, when it alters the efficiency of synaptic transmission (functional plasticity). The 
psychologists Donald O. Hebb postulates how neurons respond to neighboring neuronal activity 
and change during activity: 
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“When an axon of cell A is near enough to excite a cell B and repeatedly or persistently takes 
part in firing it, some growth process or metabolic change takes place in one or both cells such 
that A’s efficiency, as one of the cells firing B, is increased ’’ (Hebb, 1949) 
The so-called firing is described as an electrically evoked signal, which spreads throughout an 
axon of one cell and is able to evoke a signal in the neighboring cell. As Santiago Ramon y Cajal 
described the neurons are separated but contiguous entities, the electrical signal of the axon of 
the one cell needs to be modulated to get a chemically signal, which is able to get through the 
synaptic cleft, the part between two neurons, to evoke another electrically signal in the 
postsynaptic cell. This is the mechanism of the signal spreading from one to another neuron. 
The long-lasting activity change of neurons is called long-term potentiation and is the process 
behind the postulate of Hebb. It was first described by Bliss and Lømo (1973) who showed long-
lasting strengthening of synaptic connections through high electrical frequency stimulation. The 
experiments of Bliss and Lømo took place in the hippocampus, a brain region which is nowadays 
highly intensive studied in terms of memory formation and activity dependent synaptic 
plasticity.  
 
1.1.1 The Hippocampus 
The hippocampus is a main part of the limbic system and the location of memory consolidation, 
the transfer of short-term into long-term memory. Indeed, hippocampal lesion studies like the 
famous H.M case could show that the hippocampus is not only the main area for the formation 
of memory, but furthermore for the recall of consolidated memory (O’Keefe and Nadel, 1978). 
H.M, a patient suffering from epilepsy underwent a surgery where the hippocampus was 
bilaterally dissected. H.M. was relieved by epilepsy and displayed an intact short-, long-term and 
working memory whereas the acquisition of new declarative memories was no longer possible 
(Scoville and Milner, 1957). The study also proofed that the hippocampus is not the region of 
memory storage. The hippocampus is able to embed the incoming information coming from the 
entorhinal cortex into context-specific depictions which are then stored in the cortex. With its 
highly organized structure including the dentate gyrus (DG) and the ammon’s horn (CA, lat. 
cornu ammonis), the hippocampus is a suitable model for studies in mammalian brains. The CA 
region can be divided into CA1, CA2 and CA3 and is forming a highly precise trisynaptic circuit. 
(Andersen, 1975) (Figure 1).  
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Figure 1: Hippocampal organization. A hippocampal transversal section labeled via Golgi method (adapted from 
hippocampus book). B Neurons of the enthorinal cortex layer II project to granule cells of hippocampal Dentate Gyrus 
and CA3 field via perforant pathway. Mossy fiber projections from granule cells project to CA3 pyramidal cells. 
Schaffer collaterals of CA3 project to CA1 pyramidal cells in the hippocampus (Patten, 2015). 
The entorhinal cortex (EC) spreads information via the perforant path to dentate gyrus granule 
cells. Axons of dentate gyrus granule cells end up in mossy fibers, which itself are connected to 
CA3 pyramidal cells. Dentate gyrus also projects to CA2 area, which itself innervates neurons of 
the CA1 region (Kohara et al., 2014). Schaffer collaterals, axons of CA3 pyramidal cells, project 
to CA1 pyramidal cells. The CA1 pyramidal neurons are connected to the subiculum, which then 
closes the loop and projects to deep layers of the EC (Andersen et al., 2006). Inhibitory 
interneurons exist in all regions of the hippocampus that mediate feed-back and feed-forward 
inhibition to assure the synchronization of the hippocampal network (Freund et al., 1996). With 
its compact but highly defined structure, the hippocampus is the perfect model system to study 
synaptic activity. Additionally, preparations of hippocampal transversal slices keep these 
neuronal projections mostly intact (Korte and Schmitz, 2016), so it is not only an interesting 
model for in vivo, but also for in vitro studies. In this dissertation I investigated synaptic basal 
activity, as well as activity-dependent modifications at Schaffer-collateral pathway in murine 
hippocampal transversal slices. 
 
1.1.2 Long-term potentiation and long-term depression  
The mammalian brain is able to change (strengthen and loosen) synaptic connections during 
activity generated by experiences. Hebb postulates in 1949, that upon distinct stimuli, a second 
neuron can increase its firing rate evoked by stimulation of a first neuron. This process, where a 
distinct high frequent stimulus leads to a persistent increase in synaptic strength over one hour 
or more is called long-term potentiation (LTP) (Bliss and Lømo T, 1973; Bliss and Collingridge 
1993), whereas on the opposite site, a low frequent stimulus can lead to a persistent synaptic 
A B 
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weakening called long-term depression (LTD) (Ho et al., 2011). Long-term plasticity is 
bidirectionally modifiable (Dudek and Bear, 1993) and interestingly the same synapse can induce 
LTP and LTD dependent on the stimulus it receives but the mechanism underlying LTP and LTD 
is not equal in all brain regions. At the mossy fiber pathway, LTP is independent from the N-
methyl-D-aspartate receptor (NMDAR) but most studies focus on NMDA receptor dependent 
LTP (Lynch, 2004), like at hippocampal CA3-CA1 pathway as well as I did in this thesis. The 
NMDAR is an ionotropic receptor which is permeable for calcium (Ca2+) and sodium (Na+). The 
ligands for NMDAR are glutamate and the co-agonist glycine or D-serine (Henneberger et al., 
2013). Under resting membrane conditions (-70 mV), NMDAR is blocked by a magnesium ion 
(Mg2+) and therefore Ca2+ and Na+ are unable to enter the cell via this receptor. Basal synaptic 
transmission is mainly mediated via another receptor called the α-amino-3-hydroxy-5-methyl-
4-isoxazole propionic acid receptor (AMPAR), which is permeable for Na+ and potassium (K+) 
ions in response to glutamate binding (Citri and Malenka, 2007). Upon entering of positive ions 
and therefore depolarization of the membrane the Mg2+ block in NMDAR can be released and it 
becomes permeable for Ca2+ and Na+ ions when glutamate binding occurs at the same time 
(Herron et al., 1986). This Ca2+ influx via NMDAR leads to the activation of downstream protein 
kinases, e.g. calcium/calmodulin-dependent kinase II (CaMKII) which in turn are responsible for 
AMPAR stabilization within the post-synaptic density (PSD) (Citri and Malenka, 2007, Korte and 
Schmitz, 2016, Barria et al., 1997). Being only conductive when pre- and post-synapse are co-
active characterizes the NMDAR as a coincidence detector. These finding defines moreover the 
first of three key features of LTP (Bliss and Collingridge, 1993):   
1) Input-specificity restricts the activation of synapses only to specific postsynaptic parts, at the 
spine head. 
2) Cooperativity means, multiple synapses need to be activated at the same time to generate a 
sufficient postsynaptic depolarization  
3) Associativity means that in a pairing protocol a weak and a strong synaptic input induce LTP 
at both synapses. 
Characteristically for NMDAR dependent LTP (and LTD) is to sustain the connection between the 
presynapse and the postsynaptic compartment. The shape of the spine head can give rise to the 
connection strength to the presynaptic part (Holtmaat and Svoboda, 2009). A lower spine head 
volume is related to a lower number of receptors for neurotransmitter and thus reflects a lower 
synaptic strength (Holtmaat und Svoboda, 2009). At basal conditions a low number of AMPAR 
are internalized into the postsynaptic membrane generating excitatory postsynaptic potentials 
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(EPSPs) upon stimulus. When an action potential reaches the presynaptic part, voltage gated 
Ca2+ channels (VGCCs) are activated and allow the influx of Ca2+, which leads to fusion of vesicles 
with neurotransmitters with the presynaptic membrane and the release of neurotransmitters 
into the synaptic cleft. These neurotransmitters like glutamate are binding to AMPAR allowing 
Na+ and Ca2+ influx into the postsynaptic compartment. The depolarization of the postsynaptic 
membrane leads to the release of the Mg2+-block from the NMDAR, which makes them 
permeable to Ca2+and Na+. The influx of Ca2+ via NMDARs activates Ca2+-dependent enzymes like 
protein-kinase C (PKA) and CamKII relief AMPAR trafficking by phosphorylation of specific 
receptor subunits. Additionally, auto-phosphorylation of the CamKII initiates downstream 
signaling cascades for example the synthesis of new proteins (Fukunaga et al., 1995). This late 
phase of LTP (L-LTP) and also of LTD (L-LTD) that lasts for hours or even days is dependent on de 
novo protein synthesis (Manahan-Vaughan et al., 2000) whereas the early phase of LTP (E-LTP), 
lasting from one to three hours is independent of protein synthesis. Not only the lasting time of 
LTP is crucial, but also the frequency of stimulus is decisive. LTP can only be induced via 
repetitive or tetanic stimulation of synapses with prolonged trains at high frequencies (Bliss and 
Lømo, 1973). In contrast, short bursts result in plasticity lasting only for milliseconds to minutes 
and are called short-term synaptic plasticity (Zucker and Regehr, 2002). 
 
1.1.3 Short-term and long-term synaptic plasticity 
Different forms of synaptic plasticity are widely discussed and are mainly distinguished by their 
duration. Unlike long-term plasticity that can last for hours or even days, preceding short-term 
plasticity (STP) only lasts for milliseconds to minutes and is thought to be involved in short-term 
memory formation as well as temporary changes in behavior due to sensory input adaption (Citri 
and Malenka, 2007). STP is a presynaptic phenomenon as Ca2+ gets transiently accumulated in 
the presynaptic terminals following short bursts of activity and therefore neurotransmitter 
release is enhanced due to biochemical processes that lead to vesicle exocytosis (Zucker and 
Regehr, 2002). By applying two stimuli within a short interval, presynaptic properties can be 
easily measured. The second stimulus can be either enhanced compared to the first one (Paired-
pulse facilitation, PPF) or depressed (Paired-pulse depression, PPD) (Katz and Miledi, 1968). 
Longer inter stimulus intervals (ISIs) lead in most synapses to PPF whereas ISIs of 20 ms or less 
lead to PPD.  In case of PPD the ready releasable pool (RRP) of vesicles in the presynapse is still 
depleted due to the first stimulation, leading to less transmitter release in response to the 
second stimulus. In case of ISIs from 20 ms up to 500 ms residual Ca2+ in the presynapse, left 
over from first stimulus, increases the release of synaptic vesicles to the second stimulus and 
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lead to PPF (Zucker and Regehr, 2002). Additional mechanisms are thought to be involved as 
well, like activation of protein kinases regulating the activity of presynaptic proteins like the 
phosphoprotein synapsin (Rosahl et al., 1993). Interestingly, the same synapse can be more 
prone to PPF or PPD depending on their history. A synapse with low probability of transmitter 
release will show a depression due to the second stimulus, whereas a synapse with high 
transmitter release probability will show facilitation due to second stimulus applied (Dobrunz et 
al., 1997). In addition to the briefly lasting forms of STP, high frequent stimuli leading to 
persistent forms that can last for several seconds up to minutes, called post tetanic potentiation 
(PTP) and augmentations, lasting five to ten seconds (Citri and Malenka, 2007; Regehr, 2012). In 
both cases, high amounts of Ca2+ and biochemically alterations of proteins in the presynapse 
lead to a higher probability of synaptic vesicle release and therefore to high amount of 
neurotransmitter release (Zengel and Magleby, 1982). PTP is characterized by a large 
enhancement of synaptic efficacy after high frequency stimulation and displays the very first 
phase of LTP followed by STP which displays the early LTP (E-LTP) phase up to hours. E-LTP 
describes the very first phase of LTP and lasts less than one hour whereas late LTP (L-LTP) lasts 
for hours (in vitro) up to weeks or even months (in vivo) (Citri and Malenka, 2007). Taken 
together STP is acting like a processing filter between neurons, whereas LTP and LTD display 
learning and memory formation at a cellular level. The understanding of their mechanisms on a 
cellular level is very important with respect to neurodegenerative diseases.  
 
1.2 Alzheimer’s disease 
One of the most commonly studied neurodegenerative disease besides Parkinson’s and epilepsy 
is Alzheimer’s disease (AD). AD is the most common cause of dementia with 60 to 80 percent of 
the cases. In 1901 Alois Alzheimer described the first case of AD on his 51-year-old patient 
Auguste Deter who suffered from various symptoms like depression, disorientation and 
progressive memory loss and finally died at the age of 55. After her death the brain underwent 
an autopsy and Alois Alzheimer himself described his finding as follows: 
‘’Finally, the nucleus and the cell itself disintegrate and only a tangle of fibrils indicates 
the place where a neuron was previously located.’’ (Alzheimer, 1907) 
These findings display the typical biochemical symptoms of AD, on the one hand a progressive 
extracellular accumulation of the amyloid-β (Aβ) protein resulting in so called amyloid plaques 
and on the other hand the formation of intracellular neurofibrillary tangles (NFTs) resulting 
finally in neuronal death. Plaques as well as NFTs can be observed in brain regions that are 
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mainly involved in learning and memory as well as emotional behavior like hippocampus, 
entorhinal cortex and amygdala. NFTs are resulting from aggregation of biochemically changed 
microtubule associated protein tau, leading nearby neurons to reduced numbers of synapses as 
wells as neuronal death (Goedert et al., 1988). In the healthy brain the microtubule binding 
protein tau is essential for the stabilization of microtubules and present in all neurons and glia 
cells. However, its hyperphosphorylation leads to self-aggregation into plaques and as a result 
into neuronal and glial death. Worldwide about 30 million people suffer from Alzheimer’s 
disease but only little is known about the factors influencing progression from mild cognitive 
impairment to AD. In 2050 the Alzheimer cases will be three times higher than now (Hebert et 
al., 2013) therefore it is important to know the mechanisms. So far known there are two 
hypothesis of AD to occur: on the one hand the familiar case of AD (FAD) in which dominant 
mutations cause early‐onset AD occur either in the protease presinilin1 or presinilin2 (PS1 or 
PS2) or in the amyloid precursor protein (APP) leading mainly to an overproduction of Aβ (Selkoe 
and Hardy, 2016). On the other hand, the non-dominant case of AD resulting from a failing of 
Aβ clearance resulting in a constant increase of Aβ in the brain. The deposition of Aβ oligomers, 
mediating toxic effects (Schaeffer et al., 2011), activate microglia and astrocytes and cause 
inflammatory responses for example the activation of the NALP3 inflammasome.  
 
1.3 Amyloid Precursor Protein Family Members 
The amyloid precursor protein (APP) is a type I integral membrane protein and localized at the 
chromosome 21 in humans. There are three major isoforms of APP: APP695, APP751 and APP770, 
differ in size respectively and are generated by alternative splicing and posttranslational 
modifications (Yoshikai et al., 1990). The protein family also includes amyloid precursor-like 
protein 1 and 2 (APLP1 and 2) in mammals. Both, APP695 as well as APLP1 are mainly found in 
neurons whereas the two longer isoforms of APP and APLP2 can also be found in other tissues. 
Because of its extensive post-translational processing resulting in a variety of cleavage products 
it is very hard to figure out the exact function of APP. Investigations so far could show various 
functions of APP in development, where it is spread nearly throughout the whole body and had 
additionally multiple functions also in the adult CNS (Aydin et al., 2012). 
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1.3.1 APP processing pathways 
Members of the APP protein family undergo a complex but comparable processing pathway due 
to a high degree of sequence homology (Figure 2). 
 
Figure 2: Processing pathways of APP. APP can be processed via α-, β-, η-, and γ-secretases. Α-secretase cleavage 
belongs to the non-amyloidogenic pathway, shown in the middle figure sector. This processing pathway leads to the 
formation and release of APPsα into the extracellular. Subsequently cleavage of membrane anchored CTFα by γ-
secretase leads to the formation of extracellular p3 peptide and cytoplasmic AICD containing the highly conserved 
interaction motif YENPTY (yellow stripe). Cleavage of the ms APP by β-secretase generates extracellular APPsβ and 
the membrane attached CTFβ. Further cleavage of CTFβ by γ-secretase generates cytosolic AICD and the very short 
peptide Aβ. The third processing pathway of APP is via the η-secretase, generating membrane bound CTFη and APPsη 
in the extracellular space. Further cleavage of CTFη by γ-secretase leads to cytosolic AICD. Cleavage of CTFη via β-
secretase generates the extracellular Aη-β, whereas cleavage via α-secretase generates the longer Aηα peptide 
(reproduced from Ludewig and Korte, 2017). 
The full-length Protein APP can be cleaved via three pathways depending on the kind of 
secretase in the non-amyloidogenic, amyloidogenic or as a new study have shown via the η-
secretase pathway (Willem et al., 2015). Cleavage of APP with the α-secretase, in neurons mainly 
ADAM-10 (α-disintegrin and metalloproteinase), is leading to APPsα and the membrane 
attached CTFα (Jorissen et al., 2010; Kuhn et al., 2010). Further cleavage by the γ-secretase 
generates the extracellular p3 fragment and AICD (APP intracellular domain) in the cytoplasm. 
BACE-1 (β-site APP cleaving enzyme) is the most common protein for β-secretase cleavage 
leading to extracellular APPsβ and membrane anchored ACID (Cao and Sudhof, 2001. γ-
secretase cleavage generates the extracellular Aβ fragment and again the cytosolic ACID. As APP 
is present in dendrites as well as in axons it can be released from both (DeBoer et al., 2014). In 
the healthy organism APP is cleaved in 90% of the cases in the non-amyloidogenic pathway and 
η-secreatse 
pathway 
non-amyloidogenic 
pathway 
amyloidogenic 
pathway 
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thus preventing the secretion of Aβ. A recent study of Willem et al. (2015) could show a new 
cleavage pathway besides the amyloidogenic and non-amyloidogenic pathway via the η-
secretase. In this pathway a cleavage site in extracellular domain of APP lead to a short 
extracellular APPsη ectodomain. There are some studies about the function of Aηα and one 
hypothesis is an impairment of hippocampal LTP. Previous studies with acute application of 
synthetic Aηα on hippocampal slices lead to a decreased and unstable LTP (Willem et al., 2015). 
Cleavage of the membrane anchored CTFη via α- or β-secretase is generating two peptides, on 
the one hand processing via α-secretase releasing Aηα and on the other Aηβ is generated, when 
cleaved via β-secreatse (Willem et al., 2015). Depending on the site of release, the generated 
fragments could interact with receptors or intracellular by activating signaling cascades.  
 
1.3.2 Function of APP and its cleavage products 
During the last decades, research focusses on the function of APP and its cleavage products as 
they have multiple functions in regulating biological processes in the body and the nervous 
system (Aydin et al., 2012). Depending on their processing, they can act as a receptor on the cell 
surface or as a ligand in case of Aβ binding to the full-length protein (Lorenzo et al., 2000). Cell-
cell interacting has been described for APP localized at the cell surface (Soba et al., 2005), which 
is essential to form synaptic contacts and is therefore crucial for synaptic plasticity. A recent 
study (Mayer et al., 2016) identified APLP1 as a protein mediating neuronal adhesion in a 
dynamic way, whereas APP and APLP2 are processing basal adhesive functions. These distinct 
functions of the APP family members allow the brain to act on synaptic plasticity very precisely 
and modulate synaptic function in a certain manner. The soluble APPsα fragment is well studied 
and involved in many neuronal processes like synaptic plasticity and memory enhancement as 
well as in neuroprotection (Turner et al., 2003; Copanaki et al., 2010). Aβ peptide in contrast 
seems to have only negative effects on synaptic plasticity via formation of oligomers, as it is the 
main player in AD it is investigated in an extensive way (Walsh and Selkoe, 2007; Reinhard et al., 
2005). Nevertheless Abramov et al. showed in 2009 that Aβ could have a positive influence: a 
positive endogenous regulation of the release probability at synapses in the hippocampus. In 
small amounts Aβ is acting positively on LTP as well as STP and can enhance PPF (Abramov et 
al., 2009; Wang et al., 2012; Puzzo et al., 2008). Even the shortest part of APP the intracellular 
domain (AICD) can interact with its YENPTY motif and might regulate transcription via the 
interaction with several proteins like Fe65 or mint proteins (Cao and Sudhof, 2001; Borg et al., 
1996). Mice lacking the YENPTY motif show impaired induction as well as maintenance of LTP 
and altered hippocampal dependent behavioral functions (Klevanski et al., 2014). APPsß as well 
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as APPsα are shown to be involved in inflammatory events, activating microglia cells. In the 
presence of APPsß, APPsα increases activation markers in microglia and enhance their 
production of neurotoxins but in the absence of APPsβ, APPsα is acting in a neuroprotective 
manner (Barger and Harmon, 1997). Various studies could proof a positive effect of APPsα on 
LTP. Ishida et al., could show in 1977 that the extracellular domain of APP is able to facilitate LTP 
induction in hippocampal slices. Additionally, the rescue of the LTP deficits in APP/APLP2 cDKO 
mice through the acute application of the recombinant peptide in vitro (Hick et al., 2015) show 
a rapid rescue effect. Moreover, a recent study showed that recAPPsα is able to rescue age 
dependent LTP deficits (Moreno et al., 2015). Also, on morphological level APPsα has an 
essential role on structural plasticity in the brain. It is responsible for spine density regulation as 
well as spine dynamics (Tyan et al., 2012; Weyer et al., 2011). Reverse experiments by knocking 
out the major α-secretase, ADAM-10, responsible for APPsα processing, resulted in strongly 
impaired LTP (Prox et al., 2013). Besides all the knowledge about supporting LTP it is still unclear 
how and on which receptor APPsα is acting. There might be some hints towards acting directly 
at the presynaptic part by influencing the NMDAR function (Taylor et al., 2008). 
 
1.4 Inflammatory processes 
Even in the healthy brain inflammatory processes occur all the time. Small neuronal damages as 
they occur in the daily life for example due to aging processes or small injuries, lead to an instant 
activation of the immune system of the brain. Therefore, especially microglia cells, macrophages 
of the brain, are essential. Microglia contain small inflammatory machineries to recognize 
potential risk factors (Andreasson et al., 2016). On the other hand, consistent activation of 
microglia cells occurring within age or neurodegenerative diseases lead to chronic inflammation 
and neuronal damage (Streit at al., 2014; Heneka et al., 2014). In this study especially the NALP3 
inflammasome was investigated. 
 
1.4.1 NALP3 inflammasome and microglial cells 
Microglial cells, a special form of glial cells in the brain, reflect a large part of the inflammatory 
system in the central nervous system (CNS). In the healthy brain, they form a dense network 
around neurons and are responsible for example for synapse formation and the release of 
neurotrophic factors (Figure 3) (Heneka et al., 2014). They act as special macrophages in the 
central nervous system and react quickly to pathogenic infections or other messengers like Aβ 
in AD. The immune response let the microglia change its phenotype to an activated form. Due 
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to the release of proinflammatory mediators, such as cytokines (interleukin 1 beta or interleukin 
10 (Norden et al., 2016))or reactive oxygen species, neurodegenerative diseases can be 
triggered (Saijo und Glass, 2011). Therefore, it is important not only to see neurons and the 
immune system as individual components, but to look at them together to find out whether 
hyper- or hypo-activation of the immune system with age can lead to damage to the brain (Lucin 
and Wyss-Coray, 2009). The activated form of microglia shows phenotypical markers as they 
have thicker, less branched microglial spouts (Cunningham, 2013). The activation occurs via 
pattern recognition receptors (PRR) or other surface receptors like the toll-like receptors (TLR) 
(Andreasson et al., 2016). Activation can take place via pathogenic associated molecules or via 
cell internal molecules (Saresella et al., 2016). These internal molecules can be oxidized 
mitochondrial DNA, which can be released for example under stress (Latz et al., 2013). The 
spectrum of activation results in either an M1 or M2 phenotypes. The M2 phenotype is 
characterized by an increased release of neurotrophic factors such as brain-derived 
neurotrophic factor (BDNF) or parallel phagocytosis of damaged neurons (Heneka et al., 2014). 
On the other hand, however, activation can result in a microglia M1 phenotype. In this case, the 
secretion of neurotrophic factors is downregulated. Instead, there is a release of 
proinflammatory cytokines, which can cause significant damage to the neurons leading to 
chronic inflammation and structural damage to neurons (Heneka et al., 2014). 
 
Figure 3 Activation of microglia cells. In the healthy brain, microglia form a dense network. They are responsible for 
eliminating inactive synapses or emitting neurotrophic factors to ensure the growth and stability of neurons. Through 
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surface receptors, such as TLRs, DAMPs are detected and lead to activation of the microglia. This activation can result 
in either the M1 or M2 phenotypes. While the M2 phenotype uses neurotrophic factors or phagocytosis of inactive 
synapses to rid the brain of harmful substances and reduces damage to neurons, the M2 phenotype leads to chronic 
Inflammation. TLR = "toll-like" receptor, PRR = "pattern recognition" receptor, DAMP = "damage-associated molecular 
pattern," ARG = arginase, IL = interleukin, IDE = "insulin-degrading" enzyme, iNOS = "inducible nitric synthase," ROS 
= "reactive oxygen species" (Heneka et al., 2014). 
The NALP3 domain of the NALP3 Inflammasome is localized in microglia cells and contains three 
different domains: nucleotide-binding oligomerization domain (NOD), leucin rich repeat (LRR) 
and pyrin domain-containing 3 (PYD). NALP3 itself is part of the NALP3 inflammasome, which is 
made up of three different subtypes: NALP3 (also known as NLRP3), ASC (apoptosis-associated 
speck-like protein, which contains a CAR (caspase recruitment domain) and pro-caspase 1 (Saijo 
and Glass, 2011, Strowig et al., 2012). The inflammasome thus represents a multiprotein 
complex (Jin et al., 2010). In addition to the NALP3 inflammasome, there are other 
inflammasomes, localized in different regions and cell types. One of these is the NALP1 
inflammasome, which is mainly found in neurons or pyramid cells and oligodendrocytes 
(Kummer et al., 2007) and is one of the mainly anti-microbial inflammasomes (Coll et al., 2015). 
However, this work deals exclusively with the NALP3 inflammasome. The NALP3 inflammasome 
activation takes place in two steps. The first step involves activating nuclear factor ' kappa-light-
chain-enhancer ' activated B-cells (NFκB), a transcription factor that in turn is responsible for the 
expression of the inactive form of NALP3 (Bauernfeind et al., 2009). The second step is the 
activation of NALP3. NALP3 and ASC contain a pyrine domain, which binds together and thus 
activates the NALP3 inflammasome, followed by an oligomerization, which means that CAPS1 
binds to the CARD domain of ASC (Rathinam et al., 2012). The active inflammasome now 
processes and secretes IL-1β, which is previously present as an inactive form (Abderrazak et al., 
2015). Due to the missing of a signal peptide, the pro-shape of IL-1β is inactive. Accordingly, it is 
present within the cell and cannot cause any damage to the brain (Dinarello, 1998). Active IL-
1β, on the other hand, is the main player in infections and leads to chronic brain inflammation 
(Martinon et al., 2002). Persistently high levels of IL-1β lead to deficiencies in spatial learning 
(Moore et al., 2009), altered eating and drinking behavior, limited social contact and altered 
exploratory behavior (Goshen and Yirmiya, 2009) 
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Figure 4 Activation of NALP3 inflammasome. The NALP3 inflammasome consists of NALP3, which binds via the 
pyridine domain ASC and is thus activated. It then oligomerizes and recruits IL-1β using the CARD domain Caspase-1. 
The now active NALP3 inflammasome. CARD = "caspase recruitment" domain; LRR = "leucine-rich repeat"; NIGHT 
NBD = nucleotide binding domain; PYD = Pyrin domain; CAP1 = Caspase-1, IL-1β = interleukin 1 beta (Abderrazak et 
al., 2015). 
 
1.4.2 Inflammation in physiological aging 
Changes of microglial cells towards its active form are also found in the aging brain (Streit et al., 
2014). Internal molecules like oxidized, mitochondrial DNA, which can be released for example 
under stress, are elevated with age (Latz et al., 2013). Previous studies (Heneka et al., 2013), 
could show specific markers for the M2 phenotype of microglia found after deletion of NLRP3 in 
16 months old mice. This means that the KO of NLRP3 in older animals can have a positive effect 
on the microglial cells in the brain. Another study from Youm et al. (2013), which shows that the 
IL-1β concentration in 23 months old NLRP3 KO mice is decreased and instead the concentration 
of BDNF is increased. If microglia change their phenotypes to an M2 phenotype, the 
neurotrophic factor BDNF is increased, the IL-1β secreted by NALP3 and processed is reduced 
and age-related damage to neurons is not as pronounced (Heneka et al., 2014; Norden et al., 
2016; Saijo und Glass 2011). A study by Lamason et al., in 2006, in the murine spleen of 24-28 
weeks old mice shows that female mice have an increased expression of genes of the adaptive 
immune response, while males show an increased expression of genes of the innate immune 
response. This may suggest that the effects of the NLRP3 KO have a greater impact on females. 
Furthermore, it has been shown that the activation of the NALP3 inflammasome can promote 
estrogen-mediated anxiety and depression (Xu et al., 2015). The inverse conclusion would be 
that female mice with a knockout in NALP3 inflammasome would have a beneficial phenotype 
compared to male mice in terms of anxiety behavior and depression. In general, human aging is 
characterized by a chronic and low-grade inflammation (Franceschi and Campisi, 2014). As most 
age-related diseases share an inflammatory pathogenesis, inflammation is a highly significant 
risk factor for both morbidity and mortality in the elderly people (Franceschi et al., 2006). 
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Another source of inflammation during age might be represented by harmful products produced 
by the microbial constituents of the human body, such as gut microbiota, which can leak into 
surrounding tissues as well as circulation (Biagi et al., 2011). Therefore, the ability of the gut to 
secrete these microbes and/or their products declines with age, leading to chronic low-grade 
inflammation. Another possibility is that the gut microbiota itself change with age so that the 
microbes present in the aged gut elicit an inflammatory response. Taken together, the host–
pathogen balance is very important (Biagi et al., 2011).  
 
1.5 Autoimmune antibodies 
Not only during age, but also in young people, some molecules like body-own antibodies can 
lead to chronic inflammation. The second most frequent form of Autoimmune-mediated 
encephalitis (AE) is associated with autoimmune antibodies (AAB) against leucin-rich glioma-
inactivated protein 1 (LGI1) (Van Sonderen et al., 2016; Arino et al., 2016). LGI1 is a secreted 
protein and consists of two major motifs: a leucin-rich repeat (LRR) section for LGI1/LGI1 
interaction and an epitempin (EPTP) section mediating the interaction of LGI1 and the α-
disintegrin and metalloproteinase (ADAM22) receptor , following the formation of a tetramer 
(Fukata et al., 2006; Yamagata et al., 2018). This tetramer is crucial for synaptic transmission by 
interaction with presynaptic Kv1 channels and postsynaptic AMPA receptor (Fukata et al., 2006, 
2017; Seagar et al., 2017). Application of AAB from LGI1 AE patients on hippocampal slices 
interrupted the LGI1-ADAM22 interaction and lead to a decrease in AMPAR density and 
therefore a decreased synaptic transmission level (Ohkawa et al., 2013). This finding of Ohkawa 
was strengthened by Petit-Pedrol and colleagues in 2018 using chronic infusion of LGI1-AABs 
enriched CSF resulting in a decrease of AMPA receptors and Kv1 channels. Patients suffering 
from AE usually have initially facial brachial dystonic seizures (FBDS) a form of epilepsy, which is 
characterized by frequent, brief seizures affecting arm and face. Immunosuppressive therapy of 
LGI1 AAB-associated encephalitis in this early stage of the disease is efficient (Irani et al., 2013; 
Thompson et al., 2018). At the stage of FBDS a magnetic resonance imaging (MRI) displays a 
predominantly physiological phenotype (Navarro et al., 2016; Miller et al., 2017; Thompson et 
al., 2018) whereas patients with limbic encephalitis develop a hippocampal atrophy (Heine et 
al., 2018). Unaltered MRI results in the early stage of AE make it hard to determine the disease. 
Subsequently, the clinical phenotype changes to epilepsy and cognitive decline (Van Sonderen 
et al., 2016; Irani et al., 2012, 2013) and therefore AABs are involved in neurodegenerative 
processes leading to dementia-like-symptoms (Dalmau et al., 2008: Doss et al., 2014). 
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1.6 Sex dependent differences in health and disease 
It is well known that various diseases show a sexual prevalence. Just to mention some examples: 
women are nearly twice as likely diagnosed with depression compared to men (Krishnan and 
Nestler, 2010) and many disorders linked to autoimmune etiologies, for example multiple 
sclerosis are predominantly female specific (Whitacre, 2001; Werling and Geschwind, 2013). 
Males are more likely to suffer from autism spectrum disorder (ASD) additionally 
neurodevelopmental disorders, like attention deficit hyperactivity disorder and language 
impairment show a male bias (Viding et al., 2004; Szatmari et al., 1989). However it is not entirely 
clarified about the biochemically mechanisms behind the sexual addiction of some diseases, the 
study of Sarubin and colleague in 2017 supports the notion of an association between variants 
of glucocorticoid receptor (GR) related genes in women and the pathophysiology of depression: 
females suffering from major depressive disorder showed a more than three times higher 
frequency of the Thymin/Cytosin polymorphism compared to controls, which thus seems to be 
one reason for sexual differences in depression associated diseases. This result correlates with 
the fact that also in AD woman are predominantly affected (Seshadri et al., 2006).  
 
1.6.1 Differences in immune associated molecules in male and female brain 
New research could show that microglia are not only essential for neuroinflammatory processes 
like clearing of debris and neuroprotection but are also active players in many basic processes 
in the healthy brain including brain development and sexual differentiation in the brain (Schwarz 
and Bilbo, 2012). For example, in processes like cell proliferation, synaptic connectivity and 
physiology microglia cells are main players (Lenz and McCarthy, 2014). In the developing rodent 
brain males have more microglia cells than females across the neonatal period. Currently it is 
not known whether there are more microglia progenitor cells recruited into the male brain in 
early life, whether more cells survive in males than females or whether there is enhanced 
proliferation in the male brain (Lenz and McCarthy, 2014). Additionally, microglia are involved 
in regulating synaptic patterning selectively in males versus females thus influencing 
neighboring neurons and astrocytes. Steroid hormone signaling initiated in neurons leading to 
microglial release of prostaglandins as an essential contributor to the induction and 
maintenance of dendritic spine excitatory synapses in the developing male brain (Lenz and 
McCarthy, 2014). Therefore, not only in diseases, but also in the physiological development of 
the male and female brain differences occur which are leading to altered functions of the 
immune system in the brain between sex. The sex dependent differences in the mammalian 
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brain during inflammatory processes are still few investigated. Therefore, I analyzed the NALP3 
Inflammasome in terms of sex dependent differences within age. 
 
1.7 Scope of this Study 
AD is one of the most common neurodegenerative disorders with increasing numbers of 
patients every year. Some studies indicate that the full-length APP as well as some other APP 
cleavage products act in a neuroprotective way, but Aβ is the main player acting in the process 
of progressive decline of synapses occurring due to its oligomerization finally resulting in cell 
death. This mainly occurs in the hippocampus, the brain region responsible for memory 
formation. Recent studies could also indicate that autoimmune antibodies involved in 
neurodegenerative processes in the hippocampus lead to dementia-like-symptoms. With its 
binding to LGI1 the interaction of LGI1/ADAM22 gets interrupted, which is crucial for synaptic 
transmission by interaction with presynaptic Kv1 channels and postsynaptic AMPAR. This is 
resulting in a decrease in AMPAR density further to a decreased synaptic transmission level and 
finally synaptic death. Cell death therefore is responsible for activation inflammatory signal 
processes spreading for example debris, which in turn causes the activation of inflammatory 
processes. One major inflammasome in the mammalian brain is the NALP3 inflammasome 
mainly located in microglial cells. Activation of it through surface receptors acting on 
inflammatory signals, leading to clearance of damaged neurons in turn resulting in fewer 
synaptic connections. The KO of the NALP3 inflammasome is leading to sex dependent outcomes 
in electrophysiological measurements during aging.  
In this study, I will make a possible connection via inflammation between common diseases like 
AD, autoimmune antibodies and inflammasomes. I analyzed the function of APPsα, a cleavage 
product of the APP family, in terms of LTP and get rise to a potential receptor of APPsα. 
Additionally, I analyzed the electrophysiological as well as morphological function of human 
autoimmune antibodies on murine hippocampal slices. Moreover, I included a sex dependent 
view on the involvement of inflammasomes on synaptic degeneration during age. 
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2. Materials and Methods 
2.1 Mice strains and Patient samples 
2.1.1 Mice stains 
2.1.1.1 NLRP3 KO mice 
To investigate the role of the NALP3 inflammasome complex on physiological aging of mice a 
knockout mice strain was created. Briefly, the generation of NLRP3-/- mice was performed as 
follows: The NLRP3 KO animals are based on a homozygous knockout of an intracellular sensor 
of the NALP3 inflammasome. This sensor is activated by molecular structures resulting from cell 
damage or pathogens. The mice have no inferior phenotype compared to the WT. In old age, KO 
animals have an advantageous phenotype in many areas (motor function, bone density, etc.). 
They were generated in Bonn in the group of clinical neurosciences under Prof. Eicke Latz and 
were kindly provided for this work (Heneka, 2013). 
 
2.1.1.2 Htau.P301S mice 
For the Alzheimer’s disease studies a mouse line was used that express, under the control of the 
murine Thy1.2 promoter, the 383 amino acid-long alzheimer-associated human tau isoform with 
mutations at position P301S. This htau.P301S mouse line displays a progressive tau pathology 
that starts at the age of 2 months and is characterized by tau hyperphosphorylation. At the age 
of 2.5 months, brain tauopathology is accompanied by a reduction of excitatory postsynapses, 
so called spines, in the hippocampus. This is associated with impairment of spatial memory. At 
the age of about 4 months, mature tau aggregates and tangles develop, as they are also found 
in AD patients (Figure 5). This line also shows tau expression in motor neurons of the lumbar 
spinal cord and thereby degeneration of motor neurons. This leads to progressive impairments 
of motor coordination and locomotion, increased weight loss, a neurological phenotype with 
"hind feet clasping" and finally a progressive paralysis of the hind legs, which requires euthanasia 
of the mice (Allan et al., 2002; Schindowski et al., 2006). 
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Figure 5: Phenotype of the htau.P301S mouse line. This mouse line expresses the 383 amino acid-long Alzheimer-
associated human tau isoform with mutations at position P301S under the control of the Thy1.2 promotor. Cognitive 
deficits and reduced spine density at the age of 2.5months with tangles in cortex and hippocampus at the age of 4 
months are the consequences. Progressive loss of motor neurons and therefore deficits in locomotion and motor 
coordination as well as weight loss and finally paralysis of the hind feet leads to euthanasia of the mice (adapted from 
U. Müller, unpublished). 
 
2.1.1.3 NexCre cDKO APP mice 
To circumvent lethality of APP/APLP2 double KO mice and to elucidate the role of APP and APLP2 
in the adult CNS Hick et al., generated animals with a conditional CNS specific APP/APLP2 double 
knockout (cDKO). They crossed APPflox/flox/APLP2-KO mice to NexCre mice leading to APP gene 
deletion selectively in excitatory forebrain neurons of the cortex and hippocampus. Generation 
of NexCre cDKO mice was done by crossbred of three mice strains: APPflox (Mallm et al., 2010), 
APLP2-KO (von Koch et al., 1997) and NexCre (Goebbels et al., 2006). Final mating were 
APPflox/flox/APLP2−/− × APPflox/flox/APLP2−/−/NexCre+/T expressing Cre prenatally (from about E11.5 
onwards) in postmitotic neuronal progenitor cells as confirmed by crosses to Cre reporter mice 
(Hick et al., 2015).  
 
2.1.1.4 Aηα injection 
Viral Aηα injection was performed in Heidelberg in the lab of U. Müller. WtR6 littermate control 
(LM) animals were injected with a vector only containing Venus (pAAVss-Syn-lckVenus (1x10e9)) 
whereas Aηα injection was performed with two different titer pAAVss-Syn-lckVenus-T2A-Aη-α 
(1*10e9) and pAAVss-Syn-lckVenus-T2A-Aη-α (1*10e10). Three weeks after injection the 
pyramidal cell layer of CA1-CA3 hippocampal neurons was intact. Injection took place four weeks 
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before starting electrophysiological experiments. Fluorescent signal in the CA1-CA3 and DG 
hippocampal region was tested right before measurements to be sure of vector expression. 
2.1.2 Patients samples 
This part of the study is approved by the ethics committee of the university hospital Magdeburg 
and every patient gave written and informed consent. LGI1 Patient1 was admitted with a limbic 
encephalitis (LE) after a series of four grand mal seizures on one day and MRI-FLAIR intense 
lesion in the hippocampus. Investigation on previous symptoms revealed no signs of FBDS, no 
cognitive decline and no complex partial seizure before admission. Immunosuppressive therapy 
was initiated in Patient1 and Patient2 including plasma exchange, methylprednisolone (MP) and 
long-term immunosuppression with Rituximab. Patient3 returned to normal after recurrent MP. 
Patient1 returned almost back to normal with only subjective attentional and amnestic deficits. 
Patient2 and Patient3 had a normal performance in recurrent CERAD plus test (Consortium to 
Establish A Registry for Alzheimer's Disease). CERAD is a collection of different dementia tests 
to assess the severity of dementia. 
 
2.2 Acute hippocampal slices 
2.2.1 ACSF’S 
ACSF is used to obtain best conditions for the slices during preparation, cutting and 
measurements. To achieve these properties, the ACSF needs to contain all important ions and 
glucose for optimal neuronal function (see Table 1). To supply the tissue with an adequate 
amount of oxygen and to reach a physiological pH of 7.3 the ACSF was constantly carbogenated 
(95% O2, 5% CO2). In this study for preparation and electrophysiological recordings two 
different ACSFs were used depending on LTP or LTD measurements. Both ACSFs contained a high 
Mg2+ concentration of 2 mM to prevent a prematurely release of the Mg2+ block from the NMDA 
receptor which would result in a pre-potentiation in the acute slices due to stress resulting from 
the preparation steps.  
 
2.2.2 Preparation of acute hippocampal slices 
For the preparation of acute transversal hippocampal slices, mice were briefly anesthetized with 
Isoflurane and rapidly decapitated. The skull was opened, and the brain was removed. It was 
immediately transferred into ice-cold, carbogenated (95 % O2 and 5 % CO2) artificial cerebral 
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spinal fluid (ASCF) for three minutes. All following steps were also performed in ice-cold ACSF to 
prevent oxidative stress. 
For preparation of the hippocampi the cerebellum and a part of the forebrain containing the 
olfactory bulb was removed via a razor blade. In the next step the two hemispheres were 
separated by a razor blade as well. To uncover the hippocampus, the hemisphere was placed 
with the cerebellum to the top and the striatum was removed with two rounded spatulas from 
the medial side. The first spatula was placed directly under the fimbria hippocampi to loosen the 
hippocampus and the second spatula dissecting it from the subiculum. Afterwards the 
hippocampus could be easily folded out of the remaining cortical tissue.  
 
Figure 6: Location of the hippocampus in the rat brain. A Schematic illustration of the location of both hippocampi 
in the rat brain. B Alignment of the hippocampus to the agar block and preparation of 400μm sections with the 
vibrating microtome blade. C View of the transversely cut, intact hippocampus. A = Cornu ammonis, DG = dentate 
gyrus (Hammond, 2001). 
To receive 400 µm thick transversal slices, the hippocampus was glued with the ventral part 
down on a specimen plate while leaning on an agar block with the dentate gyrus facing it (Figure 
6). The specimen plate was quickly placed into ice-cold ACSF and with the VT1200S vibrating 
microtome (Leica Microsystems, Germany) the hippocampus was cut along its longitudinal axis 
in a slow and gentle, tissue protecting manner. After cutting the slices were transferred into a 
custom-made submerged chamber to rest for 90 min in ACSF at room temperature (RT). All 
these steps together not should not exceed a time of 20 minutes. 
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Table 1: Composition of ACSFs. All Chemicals obtained from Applichem (Konnerth et al, 1984). 
Substance 
LTP ACSF 
Molarity[mM] 
LTD ACSF 
Molarity[mM] 
NaHCO3 26,0  26,0  
NaH2PO4*H2O 1,25  1,25  
NaCl 125,0  125,0  
MgCl2*6H2O 2,0  2,0  
KCl 2,5  3  
D(+)-Glucose  25,0  10,0  
CaCl2*H2O 2,0  2,5  
 
 
2.3 Electrophysiology 
2.3.1 Extracellular field recording 
For electrophysiological measurements two nearly identical setups were used. Blinded to 
phenotype, control as well as altered slices were measured alternating on both setups to create 
similar conditions. Additionally, flow rate, temperature and filter setting were kept customizable 
to achieve comparable results. With the help of a pre-programmed stimulus pattern in the 
Master trigger (Master 8 A.M.P.I., Israel), an impulse could be applied to the slices via the 
stimulus isolator (A360 or A365, WPI, USA). The signal was visualized using oscilloscope (HM507, 
HAMEG Instruments). To minimize signal interference, upstream of the recording electrode an 
amplifier was positioned (HS-2A, Axon Instruments), which strengthen the mediated signal by a 
factor of ten. In addition, the chamber and the micromanipulators were attached to a vibration-
steamed table to avoid interference in the signal. To achieve a consistent temperature, the 
chambers were placed on an aluminum heating base (PH-1, Warner Instruments). Upstream of 
the chambers an additional preheating element (in-line solution heater SC-20, Warner 
Instruments) was installed and both heating elements were connected to an adjustable Dual 
Channel Heater Controller (TC-334B, Warner Instruments). A constant temperature of 23 °C (RT) 
for fiber volley measurements and 32 ± 0.2 °C for basal recordings as well as LTP and LTD 
measurements was adjusted. To adjust flow rate peristaltic pumps (Ismatech, Switzerland or 
Abimed, Germany) were used. ACSF was led through PVC tubings (TYGONE, Ismatec) for 
standard recording whereas silicon tubings (PharMed® Ismaprene, Ismatec) were used for 
autoimmune antibody experiments and for experiments were inhibitors or peptides were 
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applied in order to prevent sticking to the tubing walls. After approximately 1.5 h of recovery 
time from preparation, slices were placed in recording chambers (RC-22, Warner Instruments, 
Conneticut, USA or custom-made, MPI Martinsried) with a continuous flow rate of 1.5 ml/min 
of ACSF using a stereo microscope (SMZ 654, Nikon, Japan or Heerbrugg at Leica Microsystems). 
Slicers were aligned with the CA3 region on the side of the mechanically adjustable stimulus 
electrode (Leitz) and with the CA1 region parallel to the electrically adjustable recording 
electrode (Wetzler and Nano stepper). Glass microelectrodes filled bubble-free with 3 M NaCl 
were used to record electrically evoked field excitatory postsynaptic potentials (fEPSP) in the 
CA1 hippocampal region. Borosilicate glass capillaries (0.58 x 1.00 x 100 mm, Biomedical 
Instruments, Germany) used as recording electrodes were pulled with a Flaming Micropipette 
Puller (P-97, Sutter Instruments, USA) generating tips of approximately 1 to 3 MΩ resistance and 
placed in CA3 Schaffer collaterals at a depth of 120-150 µm (Figure 7). 
 
Figure 7: Orientation of the hippocampus within the rodent brain and placement of the stimulating and recording 
electrode in transversal hippocampal slices. Upper image section: localization of the hippocampus (dark grey) in the 
rodent brain. Transversal hippocampal slice in displayed (red) and enlarged. lower panel: anatomy of the 
hippocampus, Entorhinal cortex (EC) display starting point of signal transduction via perforant path (green) to the 
dentate gyrus (DG) granule cells or CA3 pyramidal cells or to CA1 region (red). Mossy fiber cells of DG (violet) transfer 
signals to CA3 pyramidal cells, were they are transferred via schaffer collaterals (yellow) to CA1. CA1 pyramidal cells 
deliver the Signal back to the EC (blue). For electrophysiological measurements stimulating electrode (Stim.) was 
placed in CA3 schaffer collaterals and Signal was recorded via recording electrode (Rec.) in CA1 dendrites (Korte and 
Schmitz, 2017). 
  
2.3.2 Stimulating protocols 
To investigate basal synaptic activity Input/ Output measurements were performed. Fiber volley 
measurements that reflect the presynaptic part of fEPSP, or in more detail the summation of 
action potentials of stimulated axons, were performed at RT to avoid overlapping of FV and 
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fEPSP Signal. Therefore, stimulus intensity was adjusted to fiber volley amplitudes from 0.1 to 
0.8 mV and correlated stimulus strength of fEPSP response was measured. The second method 
to investigate basal synaptic activity is the measurement of the fEPSP signal (Figure 8) in relation 
to defined current values (25-250 µA) at a temperature of 32 °C.  
2
 m
V
10 ms
EPSP slope
 
Figure 8: fEPSP Signal. Example of excitatory postsynaptic signal at 32 ± 0.2 ° C with initial stimulating artefact. Light 
grey line = negative increase in signal measured before and after LTP. 
Presynaptic function was investigated by Paired-pulse facilitation (PPF) measurements. These 
measurements are based on the probability of neurotransmitter release of the presynapse (see 
1.1.3). Through an incoming action potential at the presynapse, vesicles filled with 
neurotransmitters merge with the membrane, at the so-called active zone. By shortening the 
interstimulus intervals of the incoming signals, the neurotransmitter release occurs at even 
shorter intervals (up to 10 ms) until the presynaptic cell is no longer able to recycle the vesicles 
before the next stimulus arrives (Zucker and Regehr, 2002). Due to the remaining calcium of the 
first signal, the second signal is amplified. This type of plasticity is also called short-term plasticity 
and can take place within milliseconds (Regehr, 2015). The measurements were taken at 40% of 
the maximum rise of the signal, in which a population spike occurs, which means that not only 
the area of interest, but also nearby dendrites were stimulated. Three values were recorded for 
each interstimulus interval of 160, 80, 40, 20 and 10 ms (Figure 9). 
Materials and Methods 26 
 
1
 m
V
50 ms
 
Figure 9: Paired pulse facilitation. Various interstimulus intervals (ISI) shown. Black line left = first signal, light 
grey/white line = ISI 10 ms, light gray line = ISI 20 ms; Gray line = ISI 40 ms; Dark grey line = ISI 80 ms; Black line on 
the right = ISI 160 ms. 
To investigate long-term synaptic changes, LTP was induced. These measurements as well as 
LTD measurements took place at 32 °C. Initially and similar to PPF measurements, 40% of 
maximum fEPSP increase was defined. After 20 minutes baseline recording at 0.1 Hz, TBS 
stimulating protocol was applied (10 trains of 4 pulses at 100 Hz in an 200 ms interval, repeated 
3 times)(Figure 10).  
 
Figure 10: stimulating protocol. CA3 schaffer collaterals stimulation to induce LTP. 3 repetitions of a high frequency 
pulse were given at a distance of 10 s. This consists of 10 stimuli with a frequency of 5 Hz. Each stimulus consists of 
four pulses with a distance of 10 ms and an interstimulus interval of 200 ms. Light grey line = 1st repetition; Grey line 
= 2nd repetition; Dark grey line = 3rd repetition. 
 
2.3.3 Peptides and Proteins 
2.3.3.1 Autoimmune antibodies 
For electrophysiological autoimmune antibodies (AAB) experiments slices of adult (4 to 9 
months old) C57BL/J6 or Thy-1 mEGFP (on a C57BL/6J-SV129 background) mice were used. In a 
volume of 30 ml, which has turned out to be enough to circulate through the whole system 
during an experiment, slices were continuously incubated with either purified autoimmune 
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antibodies of three different patients or of healthy controls in a final concentration of 4 µg/ml. 
Acute hippocampal slices were pre-incubated for 1 hour or 6 hours in 10 ml gently carbogenated 
ACSF containing autoimmune antibodies of the three different patients or healthy controls.  
 
2.3.3.2 APPsα and BTX 
For investigations on the NexCre cDKO APP mouse line, recAPPsα and α-Bungarotoxin was 
applied to the acute hippocampal slices during the experiments. In a volume of 30 ml, recAPPsα 
or recAPPsα together with α-Bungarotoxin (BTX, Merck Millipore, Germany) has been solved in 
a final concentration of 10 nM based on previous acute peptide recordings with recAPPsα (Hick 
et al., 2015). Acute slices were pre-incubated with 10 nM recAPPsα alone or 10 nM recAPPsα + 
10 nM BTX for 1 hour or treated with 10 nM BTX acutely for 10 minutes before baseline 
recording. After 1.5 h resting time, after preparation, slices were transferred to a submerged 
recording chamber where fEPSP recording was performed at the CA3-CA1 pathway. ACSF with 
10 nM recAPPsα or recAPPsα + 10 nM α-BTX circulated continuously throughout LTP recording. 
To further avoid osmolality changes caused by evaporation, moisturized carbogen was directed 
in the 30 ml recording solution which was additionally covered with Parafilm® (Bemis, USA).  
 
Figure 11: Experimental setup for recAPPsα, BTX measurements on NexCre cDKO APP mouse line. Acute slices of 
NexCre DKO mice were pre-incubated with 10 nM recAPPsα alone (red) or 10 nM recAPPsα + 10 nM BTX (blue) for 1 
hour or treated with 10nM BTX acutely 10 minutes before baseline recording (green). After 1.5h resting time 
(including pre-incubation), after preparation, slices were transferred to a submerged recording chamber where fEPSP 
recording was performed at the CA3-CA1 pathway. ACSF with 10 nM recAPPsα or recAPPsα + 10 nM α-BTX circulated 
continuously throughout LTP recording. 
 
2.3.4 Data analysis 
Electrophysiological recording data were analyzed using custom made programs (ANA-DAP 
version 4.755 or ANA-PPF version 4.2) (M. Korte and V. Staiger) generating Microsoft Excel files 
(Microsoft, USA). A manually defined window made it possible to precisely measure the negative 
fEPSP slope of fiber volley, LTP and EPSP measurements. For PPF analysis the negative fEPSP 
slope of the second signal was divided by the first using an equation ( 
𝑠𝑙𝑜𝑝𝑒𝑓𝐸𝑃𝑆𝑃2
𝑠𝑙𝑜𝑝𝑒𝑓𝐸𝑃𝑆𝑃1
)*100. 
Generated Excel files containing one single value for the fEPSP slope every 10 seconds for LTP 
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measurements were further analyzed by generating the mean value for 1 minute out of 6 single 
values. The LTP data were plotted as a relative increase compared to baseline measurements 
and calculated as follows: (
𝑠𝑙𝑜𝑝𝑒𝑓𝐸𝑃𝑆𝑃
𝑠𝑙𝑜𝑝𝑒𝑓𝐸𝑃𝑆𝑃𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒
)*100. Only experiments with variance of baseline 
under 10% were included as well as physiological LTP curves without seizures or extensive 
population spikes. Baseline synaptic transmission experiments like FV, EPSP or PPF were plotted 
as the average of three values per measured condition.  
 
2.4 Spine analysis  
2.4.1 Golgi Cox staining 
In case of NLRP3 only one hemisphere was used for electrophysiological experiment whereas 
the other one was used for morphological analysis via Golgi Cox Method. Golgi staining was 
performed as described in manufactures instructions in the GolgiStainTM Kit (FD 
NeuroTechnologies, Inc., USA). During acute hippocampal slice preparation for 
electrophysiological experiments one hemisphere remained untouched after separating the two 
hemispheres. This hemisphere was stored for two weeks at RT in equal amounts of Solution A 
and B. The mixture of solution A and B was prepared at least 24 hours before experiment and 
changed after 24 h. After two weeks, the hemisphere was transferred into solution C for two up 
to seven days and stored at 4 °C. After 24 h solution C was renewed. Brain was embedded in 2% 
Agar in 0.1 M PB and cutting of 200 µm sections took place with a vibrating microtome (Leica, 
VT1200S, Germany). Coronal brain sections were mounted on a gelatin coated slide (1 % 
gelatin/0.1 % Chromalaun) and stained as described in manufacturer’s instructions (exception: 
Xylene was replaced by Appiclear). In the last step, slices were cover-slipped with Permount 
(Fisher Scientific, Germany).  
Imaging was performed using an Axioplan 2 Microscope (Zeiss, Germany). CA1 and CA3 apical 
hippocampal dendrites (2nd or 3rd order branches) were imaged using a 63x oil objective with a 
stack thickness of 0.5 µm. In total 100 µm dendritic length was taken and divided by the number 
of spines analyzed using ImageJ (1.48v, National Instruments of Health, USA). Blinded to 
genotype two animals per genotype and five neurons per animal were at minimum analyzed. 
Using GraphPad Prism (Version, 5.01) software, data were finally analyzed.  
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2.4.2 Spine analysis in Thy-1 GFP expressing animals 
In case of AAB experiments, spine analysis was done on acute slices of Thy-1 GFP mice, 
expressing GFP in neurons under the Thy-1 promotor. Therefore, images of 30 µm thick slices 
treated long or acute with certain ABB were cut with a freezing microtome (2.5.1 Cryosections) 
and imaged with a digital camera (AxiocamMR, Zeiss, Germany) at the Axioplan2 microscope 
(Zeiss, Germany) using the 63x oil objectives. Further processing was performed with ImageJ 
(1.48v, National Instruments of Health, USA). At least 100 µm of DG, CA1 and CA3 apical 
hippocampal dendritic length (2nd or 3rd order branches) were measured and divided by the 
number of spines. Blinded to genotype and treatment three animals per genotype and five 
neurons per animal were at minimum analyzed. Using GraphPad Prism (Version, 5.01) software, 
data were finally analyzed.  
 
2.5 Immunohistochemistry 
2.5.1 Cryosections 
To determine the penetration depth of the AABs into the acute hippocampal slices during 
electrophysiological measurements, the slices were fixed in ice cold paraformaldehyde 
(Applichem, 4% w/v in 0.1 M phosphate buffer) for 1 h. Afterwards the slices were transformed 
in 30% sucrose solution (Applichem, 30% w/v in 0.1 M phosphate buffer) at least overnight. 30 
µm thick slices were cut with a freezing microtome and mounted on gelatin coated slides, dried 
for 1 h at RT and stored at 4 °C.  Secondary antibody treatment could be performed immediately, 
because slices were already treated with first antibody during electrophysiological experiments. 
Therefore, slices were washed with 1xPBS and incubated 2 h with the secondary antibody 
dilution 1:500 in PBS (Cy3-AffiniPure Rabbit Anti-Human IgG (H+L), Dianova). Afterwards slices 
were washed 5-6 times over 30 minutes with 1xPBS and DAPI (4’6-di-amidino-2-phenylindol) 
staining, diluted 1:1000 in PBS was performed for 5 minutes. Following 5-6 times washing with 
PBS, slices were mounted in Fluoro-Gel®. For analyzing the sections, they were imaged with a 
digital camera (AxiocamMR, Zeiss, Germany) at the Axioplan2 microscope (Zeiss, Germany) 
using the 10x and 20x objectives. Further processing was performed with ImageJ (Wayne 
Rasband) and Adobe Photoshop CS (Adobe, USA).  
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2.5.2 Solutions and Antibodies  
 
4% Paraformaldehyde (in 0.1 M phosphate buffer, pH 7.4)                       
40 g PFA in 500 ml warm dH2O, cool down and filtrate  
add 500 ml of 0.2 M phosphate buffer 
 
0.1M PB        
0.78 g NaH2PO4 
3.45 g Na2HPO4       
in 500 ml MilliQ water 
 
10x Phosphatebuffered saline (1 M PBS, pH 7.4)   
11.5 g Na2HPO x H2O  
2.0 g KH2PO4 
80.0 g NaCl 
2.0 g KCl  
in approx. 900 ml MilliQ water (pH to 7.4) fill up to 1 L final volume with MilliQ water  
 
Table 2: List of first and secondary Antibodies used for immunohistochemistry/immunocytochemistry. 
Antibody  manufacturer species dilution 
DAPI 
 
Applichem  
 
1:1000 
 
Anti-Human IgG (H+L) Cy3 Dianova rabbit 1:500 
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2.6 statistical analysis 
The statistical analysis was performed using Microsoft Excel or GraphPad Prism. To compare two 
different experimental conditions or genotypes an unpaired two-tailed Student's t-test was 
used. Data including more than 2 different groups were analyzed using a One-Way ANOVA 
followed by a post-hoc Bonferroni´s Test. Values of p ≤ 0.05 were considered significant and 
plotted as follows *p < 0.05; **p < 0.01; ***p < 0.001. All data shown were generated with 
GraphPad Prism with mean values ± standard error of the mean (SEM).
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3. Results  
3.1 The role of Amyloid precursor protein in synaptic plasticity  
Previous studies have shown positive functions of APP and some of its cleavage products in 
synaptic plasticity (1.3.2 Function of APP and its cleavage products). Additionally, a short 
incubation of slices with recAPPsα is enough to largely rescue the LTP deficits of NexCre cDKO 
mice (Hick et al, 2015).  As Aβ is acting negatively on neurons in neurodegenerative diseases like 
Alzheimer’s disease, APPsα was shown to have a positive effect (Fol et al., 2016), but it was not 
clear on which receptor APPsα is binding to act on synaptic plasticity. In this part of the study 
investigations on the α7-achetylcholinreceptor (α7-nAChR) and its antagonist BTX with respect 
to binding of recAPPsα took place. 
 
3.1.1 Inhibition of α7-nAChR by BTX blocks positive effects of recAPPsα on LTP 
Previous studies showed that α7-nAChR seems to be a target receptor to rescue deficits in 
hippocampal LTP in Aβ infused rats (Chen et al., 2006). Therefore, investigations on the role of 
recAPPsα in context with the α7-nAChR were done. In this part of my thesis I investigated the 
role of recAPPsα and αBTX on the α7-nACh receptor in case of electrophysiological LTP 
recordings.  
Acute slices of NexCre cDKO mice treated with recAPPsα (green) or recAPPsα with wash in of 
BTX 10 minutes before starting baseline recording (dark orange) displayed an indistinguishable 
LTP curve in induction and maintenance (Figure 12A). The application of BTX together with 
recAPPsα (light orange) on the other hand lead to a reduction of LTP induction and maintenance. 
This result is also shown in a bar graph, which shows significant differences in induction (t20-25; 
p=0.041) and maintenance (t75-80; p= 0.017) of LTP tested via ANOVA and Post-hoc Bonferroni 
test (Figure 12B). Overall these results indicate that α7-nAChR is a potential receptor for 
recAPPsα. 
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Figure 12 Reduced LTP in cDKO mice treated with recAPPsα and BTX. Field excitatory postsynaptic potentials (fEPSPs) 
of acute hippocampal slices of NexCre cDKO mice treated with 10 nM recAPPsα (green circles), 10 nM recAPPsα + 10 
nM BTX 1 h preincubation (light orange circles) or with 10 nM recAPPsα + 10 nM BTX acute treatment 10 minutes 
before Baseline recordings (dark orange circles) were recorded in CA1 region by stimulating Schaffer collateral axons 
of area CA3 at a frequency of 0.1 Hz. (A) LTP was induced by application of TBS after 20 min baseline stimulation 
(arrowhead) in slices pretreated for 1 hour with recAPPsα, recAPPsα + BTX or acute treatment of BTX 10 minutes 
before baseline measurements in slices pretreated for 1 h with recAPPsα. The LTP induction rate is shown as 
percentage % of mean baseline slope. During LTP measurement slices were continuously perfused with either 
recAPPsα or recAPPsα + BTX. RecAPPsα treated cDKO slices revealed a trend of a higher induction as well as 
maintenance of LTP compared to recAPPsα + BTX 1 h preincubation treatment. This trend is quantified in a bar graph 
(B), which shows the first (induction) and last five minutes (maintenance) of LTP.  cDKO slices treated only with 
recAPPsα (168.49±7.20) and cDKO slices treated with recAPPsα + acute BTX (159.65±7.65) show a higher induction 
compared to slices co-treated with recAPPsα and BTX for 1 h before measurements (142.57±7.75). The same trend 
could be seen also in maintenance of LTP (recAPPsα= 135.59±3.81; recAPPsα+acute BTX=132.43±4.87; 
recAPPsα+BTX=118.58±5.51). Statistics: one-way ANOVA with post hoc Bonferroni test. 
 
3.1.2 Young htauP301S mice 
Tau is a microtubule-associated protein normally found in the axons of neurons and is thought 
to promote microtubule assembly and stabilization (Polydoro et al., 2009). In young htau.P301S 
mice, mutation of tau on position 301 is leading to an AD phenotype represented by tau tangles 
in the cortex and hippocampus. Electrophysiological investigations on 10-13 weeks old 
htau.P301S mice with a mild phenotype (Figure 5) reflected by initial spine loss displayed a 
reduced induction phase of LTP compared to BL6  littermates (LM) (Figure 13A). Bar graph of the 
first five minutes after LTP induction support these findings. The mean potential value of 
littermate controls with 166.71±6.15% is significantly increased compared to young htau.P301S 
with only 142.86±6.27% (p=0.014) (Figure 13B). Maintenance of LTP in turn was 
indistinguishable between both phenotypes. The bar graph of the last five minutes of LTP shows 
quantitative results where littermate controls show a potential level of 142.89±4.86% and 
htau.P301S show 136.94±4.86% (Figure 13C). 
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Figure 13 LTP measurements on acute hippocampal slices of 10-13 weeks old htau.P301S mice. Activity-dependent 
synaptic plasticity was investigated on acute hippocampal slices of 10-13 weeks old littermate control (LM, black 
circles) and htau.P301S mice (open circles). Field excitatory postsynaptic potentials (fEPSPs) were recorded in CA1 
region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. The LTP induction rate is shown 
as percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars indicating SEM, 
n= number of recorded slices/N= number of animals. Data were analyzed by Student´s t-test. (A) After 20 min baseline 
recording, LTP was induced by application of Theta burst stimulation (TBS, arrowhead). Acute slices of htau.P301S 
mice displayed a LTP curve that is significant lower in induction compared to littermate controls. (B) Bar graph of the 
first five minutes after TBS show a significant higher induction of LTP in littermate controls (166.71±6.15) compared 
to htau.P301S (142.86±6.27) (p=0.014). (C) In comparison analysis of last five minutes of LTP is statistical 
indistinguishable in both genotypes (LM: 142.89±4.86; htau.P301S: 136.94±4.86).  
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Investigation of LTP, LTD as well as basal synaptic transmission via EPSP as well as PPF 
measurements in young htau.P301S mice were done and compared to age-matched littermate 
controls. LTD curves are indistinguishable between both phenotypes at the age of 10-13 weeks 
(Figure 14A). The quantification of the potentiation of the last five minutes of LTD recording 
mirrors these findings. Acute hippocampal slices of htau.P301S mice display potentiation levels 
of -1.08±4.22% and littermate controls -8.26±3.35% shown in a bar graph (Figure 14B). Same is 
true for the induction phase where LM control displays values of: -26.00±1.87% compared to 
those of htau.P301S with -27.67±2.07% (Figure 14C). Basal synaptic transmission reveal 
overlapping EPSP curves and PPF paradigm comparing htau.P301S and age-matched littermate 
controls (Figure 14D, E). 
 
Figure 14 LTD, EPSP and PPF measurements on acute hippocampal slices of 10-13 weeks old acute hippocampal 
slices of htau.P301S mice. Activity-dependent synaptic plasticity was investigated on acute hippocampal slices of 10-
13 weeks old littermate control (LM, black circles) and htau.P301S mice (open circles). Field excitatory postsynaptic 
potentials (fEPSPs) were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency 
of 1 Hz. The LTD induction rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 
time points and error bars indicating SEM, n= number of recorded slices/N= number of animals. Data were analyzed 
by Student´s t-test. After 20 min baseline recording, LTD was induced by application of low frequency stimulus for 15 
minutes. (A) Acute slices of htau.P301S mice displayed an LTD curve that is statistical indistinguishable maintenance 
to that of littermate controls. (B) Bar graph of the last five minutes of LTD show no significance between genotypes 
but a slight trend of an decreased LTD in htau.P301S mice (LM: -8.26±3.35; htau.P301S: -1.08±4.22). (C) Bar graph of 
the last five minutes of induction show no significance between groups (LM: -26.00±1.87; htau.P301S: -27.67±2.07). 
(D) Neuronal excitability was comparable at all stimulus intensities (25-250 µA) between genotypes. (E) PPF was not 
altered at all ISI between littermates and htau.P301S mice. 
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3.1.2.1 Increased LTP of aged htau mice rescued via application of recAPPsα 
I investigated the role of recAPPsα on LTP curve of aged htau.P301S mice and their age-matched 
littermate controls. The phenotype of the mice at this aging time point is characterized by 
cognitive decline resulting from tau tangles in hippocampus and cortex (Figure 5). Acute slices 
of htau.P301S mice (open circles) display a LTP curve that shows a trend of higher LTP at 
induction phase which is significant at maintenance compared to littermate controls (black 
circles). This increased LTP can be rescued to LM control level via application of recAPPsα for 
one hour preincubation and during measurements (grey circles, Figure 15A). These findings are 
reflected in the bar graph, showing the averaged potential levels of the first (Figure 15B) and 
last five minutes (Figure 15C). Bar graph of the first five minutes after TBS shows no significant 
differences in induction of LTP between littermate controls with 161.93±7.41% and the other 
groups. Potential levels of htau.P301S with 177.04±9.45% show no differences compared to LM  
and htau.P301S + recAPPsα with 162.32±6.62%. Potential levels of the last five minutes of LTP 
show significant increased (p=0.004) values for htau.P301S with 153.29±5.13% compared to LM 
with 127.59±5.13%. Application of recAPPsα rescues the significantly enhanced LTP back to LM 
control level with 135.64±4.31% (p=0.044). 
Results 37 
 
 
Figure 15 LTP measurements on acute hippocampal slices of 16-18 weeks old htauP301S mice. Activity-dependent 
synaptic plasticity was investigated on acute hippocampal slices of 16-18 weeks old littermate control (LM, black 
circles), htau.P301S mice (open circles) and htau.P301mice with recAPPsα application during measurement (grey 
circles). Field excitatory postsynaptic potentials (fEPSPs) were recorded in CA1 region by stimulating Schaffer 
collateral axons of area CA3 at a frequency of 0.1 Hz. The LTP induction rate is shown as percentage % of mean 
baseline slope. Data points were averaged over 6 time points and error bars indicating SEM, n= number of recorded 
slices/N= number of animals. Data were analyzed by one-way ANOVA with Bonferroni´s post-hoc test. (A) After 20 
min baseline recording, LTP was induced by application of Theta burst stimulation (TBS, arrowhead). Acute slices of 
htau.P301S mice displayed a LTP curve that is significant higher in maintenance compared to littermate controls and 
htau.P301S mice treated with recAPPsα. (B) Bar graph of the first five minutes after TBS show no significant 
differences in induction of LTP between groups, but a slight trend of an increase in htau.P301S mice (LM: 161.93±7.41; 
htau.P301S: 177.04±9.45; htau.P103S+recAPPsα: 162.32±6.62). (C) The analysis of last five minutes of LTP revealed 
significantly higher potentiation levels for htau.P301S mice (153.29±5.13) compared to the both other groups (LM: 
p=0.0004; htauP301S+recAPPsα: p=0.044). Application of recAPPsα (135.64±4.31) rescued the effect of enhanced LTP 
in htau.P301S mice towards littermate control level (127.59±5.13). 
Acute slices of htau.P301S mice displayed a LTD curve that is statistical indistinguishable 
maintained to the other groups. Interestingly, the LTD induction is strongly enhanced upon 
recAPPsα treatment, but not as stable as in LM or htau.P301S mice during 60 minutes of LTD 
recording (Figure 16A). Quantification of the last five minutes of LTD shows no significant 
differences between the three groups with: htau.P301S mice -6.53±3.88%, htau.P301S + 
recAPPsα -3.25±3.19% and littermate controls with -10.30±3.92% (Figure 16B). Potential levels 
of the first five minutes of LTD show no significance between groups with LM -20.46±3.52% and 
htau.P301S with -20.24±3.52% but a slight trend of an increase when recAPPsα is added -
30.64±4.55% (p=0.06 compared to htauP.301S, p=0.1 compared to LM)(Figure 16C). Basal 
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synaptic transmission was measured via EPSP and PPF paradigm. The neuronal excitability was 
comparable at all stimulus intensities (25-250 µA) between LMs and htau.P301S + recAPPsα, but 
impaired in htau.P301S mice compared to littermate controls reaching significance at a stimulus 
intensity of 175 µA (p=0.047). PPF was statistically not altered at all ISI between all groups. 
Interestingly, recAPPsα treatment leads to the highest PPF curve within that paradigm. 
Therefore, lower EPSP values in htau.P301S mice compared to LM could be rescued whereas 
physiological PPF paradigm gets enhanced.  
Taken together the results suggest an altered homeostasis in aged htau.P301S mice that could 
be restored under recAPPsα treatment. 
 
 
 
Figure 16 LTD, EPSP and PPF measurements on acute hippocampal slices of htau.P301S mice. Activity-dependent 
synaptic plasticity was investigated on acute hippocampal slices of 16-18 weeks old littermate control (LM, black 
circles), htau.P301S mice (open circles) and htau.P301mice with recAPPsα application during measurement (grey 
circles). Field excitatory postsynaptic potentials (fEPSPs) were recorded in CA1 region by stimulating Schaffer 
collateral axons of area CA3 at a frequency of 1 Hz. The LTD induction rate is shown as percentage % of mean baseline 
slope. Data points were averaged over 6 time points and error bars indicating SEM, n= number of recorded slices/N= 
number of animals. Data were analyzed by one-way ANOVA with Bonferroni´s post-hoc test. After 20 min baseline 
recording, LTD was induced by application of low frequency stimulus for 15 minutes. (A) Acute slices of htau.P301S 
mice displayed an LTD curve that is statistical indistinguishable maintenance to the other groups. Interestingly, the 
LTD induction is strongly enhanced upon recAPPsα treatment, but not as reduced as in LM or htau.P301S mice during 
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60 minutes of LTD recording. (B) Bar graph of the last five minutes of LTD show no significant differences between 
groups, but a slight trend of an decreased LTD in htau.P301S mice (-6.53±3.88) and an even higher effect in 
htau.P301S+recAPPsα (-3.25±3.19) compared to littermate controls (-10.30±3.92). (C) Bar graph of the LTD induction 
show no significance between groups (LM: -20.46±3.52; htau.P301S: -20.24±3.52) but a slight trend of an increase 
when recAPPsα is added (-30.64±4.55).  (D) Neuronal excitability was comparable at all stimulus intensities (25-250 
µA) between littermate controls and htau.P301S + recAPPsα, but impaired in htau.P301S mice compared to littermate 
controls reaching significance at a stimulus intensity of 175µA (p=0.047). (E) PPF was statistically not altered at all ISI 
between all groups. Interestingly, recAPPsα treatment lead to the highest PPF curve within that paradigm. 
 
3.1.3 Injection of Aηα show no effect on hippocampal synaptic plasticity 
Various cleavage products of APP are well studied at this time point. There are two physiological 
pathways that either prevent or promote Aβ generation from its precursor protein (APP), in a 
competitive manner. Here, I investigate cleavage products of a new physiological APP processing 
pathway by the η-secretase (Willem et al., 2015, Figure 2). One hypothesis is an impairment of 
hippocampal LTP due to Aηα. Previous studies with acute application of synthetic Aηα on 
hippocampal slices lead to a decreased and unstable LTP (Willem et al., 2015). Injection of mice 
took place four weeks before measurements. 
Acute slices of pAAVss-Syn-lckVenus-T2A-Aη-α (1*10e9) (open circles) and pAAVss-Syn-
lckVenus-T2A-Aη-α (1*10e10) (grey circles) injected mice display a LTP curve that is 
indistinguishable to littermate control injected pAAVss-Syn-lckVenus (1*10e9) (LM, black circles) 
(Figure 17A). Quantifications of the results are shown in a bar graph for the last five minutes of 
LTP that shows no differences between littermate control with 130.4±2.9% and Aηα injected 
mice with both titers 1*10e9 with 126.4±3.2 and 1*10e10 with 131.2±4.5% (Figure 17B). 
Neuronal excitability is comparable at all stimulus intensities (25-250 µA) (Figure 17C) and fiber 
volley amplitudes (0.1-0.8 mV) between groups (Figure 17D). PPF is not altered at all ISI (10 ms-
160 ms) (Figure 17E). 
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Figure 17 Electrophysiological measurements on Aηα injected mice. Activity-dependent synaptic plasticity was 
investigated on acute hippocampal slices of 10-15 weeks old littermate control pAAVss-Syn-lckVenus (1*10e9) (LM, 
black circles) and Aηα injected mice: pAAVss-Syn-lckVenus-T2A-Aη-α(1*10e9) (open circles) and pAAVss-Syn-
lckVenus-T2A-Aη-α(1*10e10) (grey circles). Field excitatory postsynaptic potentials (fEPSPs) were recorded in CA1 
region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. The LTP induction rate is shown 
as percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars indicating SEM, 
n= number of recorded slices/N= number of animals. Data were analyzed by one-way ANOVA with Bonferroni´s post-
hoc test. (A) After 20 min baseline recording LTP was induced by application of Theta burst stimulation (TBS, 
arrowhead). Acute slices of pAAVss-Syn-lckVenus-T2A-Aη-α (1*10e9) (open circles) and pAAVss-Syn-lckVenus-T2A-
Aη-α (1*10e10) (grey circles) injected mice displayed a LTP curve that is indistinguishable to littermate control 
pAAVss-Syn-lckVenus (1*10e9) (LM, black circles). Example traces before TBS (light line) and after TBS (strong line) 
are shown for all groups. (B) Bar graph of the last five minutes of LTP shows no differences between littermate control 
(130,4±2,9) and Aηα injected mice with both titers (1*10e9=126,4±3,2; 1*10e10=131,2±4,5).(C) Neuronal excitability 
was comparable at all stimulus intensities (25-250 µA) and fiber volley amplitudes (D) Fiber volley was comparable 
(0.1-0.8 mV) between groups. (E) PPF was not altered at all ISI (10 ms-160 ms). Injection of mice took place 4-7 weeks 
before measurements. 
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3.2 NLRP3 in physiological aging 
The study of Heneka and colleagues 2013 suggests a potential rescue effect of the NALP3 
inflammasome deficit on spine density reduction in APP/PS1 mice. They suggest that KO of 
NLRP3 has a putative positive effect on the spine loss in physiological aging as well. Therefore, I 
started measurements on NLRP3 KO mice at different ages. Extensive results on earlier time 
points are present in my Master thesis. Here, I present the results of electrophysiological and 
morphological experiments of the 24 months old NLRP3 KO mice and will compare sex 
dependent differences at all other time points.  
LTP curve of NLRP3 KO mice is indistinguishable to littermate controls in induction as well as 
maintenance (Figure 18A). Quantification of the last five minutes of LTP showed no differences 
between littermate control with 143.9±4.2% and NLRP3 KO mice with 143.2±5.3% (Figure 18B). 
Neuronal excitability was comparable at all stimulus intensities (25-250 µA) and fiber volley 
amplitudes (0.1-0.8 mV) tested (Figure 18C, D). Additionally, the presynaptic function was intact. 
PPF paradigm was not altered at all ISI between littermates and NLRP3 KO mice (Figure 18D). 
 
Figure 18 Electrophysiological measurements of 24 months old NLRP3 KO mice. Activity-dependent synaptic 
plasticity was investigated on acute hippocampal slices of 24 months old littermate control (LM, black circles) and 
NLRP3 KO mice (open circles). Field excitatory postsynaptic potentials (fEPSPs) were recorded in CA1 region by 
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stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. The LTP induction rate is shown as 
percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars indicating SEM, 
n= number of recorded slices/N= number of animals. Data were analyzed by Student´s t-test. (A) After 20 min baseline 
recording LTP was induced by application of Theta burst stimulation (TBS, arrowhead). Acute slices of NLRP3 KO mice 
displayed a LTP curve that is indistinguishable to littermate controls. (B) Bar graph of the last five minutes of LTP 
showed no differences between littermate control (143.9±4.2) and NLRP3 KO mice (143.2±5.3). (C) Neuronal 
excitability was comparable at all stimulus intensities (25-250 µA) and fiber volley amplitudes (0.1-0.8 mV) tested. (E) 
PPF was not altered at all ISI between littermates and NLRP3 KO mice. 
As there are hints towards gender differences during aging in literature (1.4.2 Inflammation in 
physiological aging) I additionally analyzed spine density as well as for electrophysiological 
measurements divided by sexes. 
 
3.2.1 Sex dependent differences occur during aging 
As I suspect sexual differences in LTP rate between sexes in very old mice. I decided to analyze 
electrophysiological and morphological measurements at different aging time points of 3, 6, 9, 
12 and 24 months to see at which time point exactly the sex dependent differences occur. 
Therefore, I performed electrophysiological measurements on LTP as well as basal synaptic 
properties via EPSP, FV and PPF paradigm. Additionally, I analyzed the CA1 apical spine density 
in the murine hippocampus. 
 
3.2.1.1 Electrophysiological analysis of 3-12 months old NLRP3 KO mice 
As the number of animals per group (N of 2 to 3) is too low at the aging time points of 3, 6, 9 
and 12 months one could only have a look at a trend. At a very early lifetime point of 3 months 
the LTP rate is nearly identically between male and female NLRP3 KO mice. Bar graph of the last 
five minutes of LTP shows no differences between female with 144.78±5.4% and males with 
138.69±5.07% NLRP3 KO mice (Figure 19A). The quantification of the last five minutes of LTP 
between female littermate controls with 144.78±5.41% and male mice with 158.41±6.6% seems 
to display a higher LTP for male mice (Figure 19A’). Quantification of the last five minutes of LTP 
at 6 months old mice shows a trend of female NLRP3 KO mice to have a higher LTP with 
171.43±8.53% compared to males with 145.01±4.92% (Figure 19B), but still no statistics possible 
due to low N. Bar graph of the last five minutes of LTP between female littermates with 
166.02±6.58% and male littermate mice with 149.3±7.3% (Figure 19B’) show a slight trend of 
decreased LTP in male mice. Bar graph of the last five minutes of LTP at the aging time point of 
9 months shows a trend of male NLRP3 KO mice to have a higher LTP with 136.16± 5.57% 
compared to females with 127.83±2.02% (C). Bar graph of the last five minutes of LTP between 
female and male littermate and mice shows a very slight trend of female LM mice to have a 
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higher LTP 140.11±7.42% compared to male mice with 132.4±4.9% (Figure 19C`). Quantification 
of the last five minutes of LTP in 12 months old NLRP KO mice show a trend of female NLRP3 KO 
mice to have a trend towards a lower LTP with 135.79±3.93% compared to males with 
160.28±9.24% but still no statistic possible due to low N (Figure 19D). Bar graph of the last five 
minutes of LTP between LM females with 147.30±7.37% and LM male with 143.1±6.9% show no 
differences (Figure 19D’). These findings indicate a fluctuation in LTP rate of NLRP3 KO mice as 
well as littermates when divided by sex.  
 
Figure 19 Bar graph quantification of the last five minutes of LTP of 3 to 12 months old NLRP3 KO mice. Activity-
dependent synaptic plasticity was investigated on acute hippocampal slices of 3-12months old littermate control 
female (LM female, light green circles), NLRP3 KO female mice (light red circles) and NLRP3 KO male mice (dark red 
circles) and quantified via analysis of the last 10 minutes of LTP. Field excitatory postsynaptic potentials (fEPSPs) were 
recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. The LTP induction 
rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars 
indicating SEM, n= number of recorded slices/N= number of animals. Data were analyzed by Student´s t-test. (A) Bar 
graph of the last five minutes of LTP show no differences between female with 144.78±5.4% and males with 
138.69±5.07% NLRP3 KO mice (Figure 19A). The quantification of the last five minutes of LTP between female 
littermate controls with 144.78±5.41% and male mice with 158.41±6.6% seem to display a higher LTP for male mice 
(Figure 19A’). Quantification of the last five minutes of LTP at 6 months old mice show a trend of female NLRP3 KO 
mice to have a higher LTP with 171.43±8.53% compared to males with 145.01±4.92% (Figure 19B), but still no statistics 
possible due to low N.  Bar graph of the last five minutes of LTP between female littermates with 166.02±6.58% and 
male littermate mice with 149.3±7.3% (Figure 19B’) show a slight trend of decreased LTP in male mice. Bar graph of 
the last five minutes of LTP at the aging time point of 9 months show a trend of male NLRP3 KO mice to have a higher 
LTP with 136.16± 5.57% compared to females with 127.83±2.02% (Figure 19C). Bar graph of the last five minutes of 
LTP between female and male littermate and mice show a very slight trend of female LM mice to have a higher LTP 
140.11±7.42% compared to male mice with 132.4±4.9% (Figure 19C`). Quantification of the last five minutes of LTP 
in 12 months old NLRP KO mice show a trend of female NLRP3 KO mice to have a trend towards a lower LTP with 
135.79±3.93% compared to males with 160.28±9.24% but still no statistic possible due to low N (Figure 19D). Bar 
graph of the last five minutes of LTP between LM females with 147.30±7.37% and LM male with 143.1±6.9% show no 
differences (Figure 19D’). 
As spine loss and therefore microglia activation increases during age, I also analyzed very old 
mice with a higher animal number to quantify the results. 
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3.2.1.2 Morphological analysis of spine density in 3- 12 months old NLRP3 KO mice 
Morphological analysis of spine density in apical CA1 region of the hippocampus was performed 
using the Golgi-Cox method. Spine density of 3 to 12 old months NLRP3 KO mice were analyzed 
and divided by sex.  At the age of 3 months the bar graph of spine density displays no differences 
between male NLRP3 KO with 1.44±0.02 spines/µm and female NLRP3 KO with 1.42±0.02 
spines/µm. Additionally, no sex dependent differences in the group of LM controls (female 
1.45±0.02 spines/µm and male 1.49±0.02 spines/µm) were found. Quantification of the spine 
density in 6 months old mice displays no differences between littermate controls (female 
1.55±0.03 spines/µm and male 1.54±0.04 spines/µm) and NLRP3 KO male with 1.47±0.04 
spines/µm and female with 1.54±0.03 spines/µm as well. At the time point of 9 months LM 
female display a slightly higher spine density rate with 1.53±0.05 spines/µm compared to male 
with 1.42±0.02 spines/µm, but this is only a trend due to low N. NLRP3 KO male with 1.54±0.02 
spines/µm and female mice with 1.57±0.03 spines/µm reveals no differences. At the age of 12 
months the spine density of NLRP3 KO male mice with 1.72±0.04 spines/µm displays a slightly 
trend of been enhanced compared to female NLRP3 KO mice with 1.63±0.04 spines/µm. 
Quantification of spine density of littermate controls shows no differences with female 
1.63±0.03 spines/µm and male with 1.60±0.03 spines/µm (Figure 20). 
 
Figure 20 Morphological analysis of spine density in CA1apical hippocampal region of 3-12 months old NLRP3 KO 
mice. Morphology was investigated on apical dendrites of hippocampal CA1 neurons stained with the Golgi-cox 
method of 3 to 12 months old littermate control and NLRP3 KO mice. Investigations toward sex dependent differences 
was done. Number of animals is too low to do statistics. Spines at five apical CA1 dendrites at 2nd or 3rd dendritic 
branches with a length of 100µm were counted per animal. Spine density is shown as number of spines per µm 
dendrite. Error bars indicating SEM, n= number of dendrites/N= number of animals.(A) Bar graph of spine density 
displays no differences between male NLRP3 KO (1.44±0.02) and female NLRP3 KO (1.42±0.02) mice at the age of 3 
months.(A’) Additionally no sex dependent differences in the group of LM controls (female 1.45±0.02 and male 
1.49±0.02) were found. (B’ and B) Quantification of the spine density in 6 months old mice display no differences 
between littermate controls (female 1.55±0.03 and male 1.54±0.04) and NLRP3 KO male (1.47±0.04)  and female 
(1.54±0.03 ). (C’) At the time point of 9 months LM female display a lightly higher spine density rate (1.53±0.05) 
compared to male (1.42±0.02). This is only a trend due to low N. (C) NLRP3 KO male (1.54±0.02) and female mice 
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(1.57±0.03) reveals no differences. (D) At the age of 12 months the spine density of NLRP3 KO male mice (1.72±0.04) 
display a slightly trend of been enhanced compared to female NLRP3 KO mice (1.63±0.04). (D’) Quantification of spine 
density of littermate controls show no differences (female 1.63±0.03 and male 1.60±0.03). 
 
3.2.1.3 Electrophysiological measurements of 24 months old NLRP3 KO mice 
At the time point of 24 months the number of animals is high enough to differentiate between 
sexes. Electrophysiological experiments as well as morphological analysis were performed to 
investigate whether the KO of the NALP3 inflammasome has a positive effect on spine density 
during physiological aging. Quantitative analysis of the last five minutes of LTP show a 
significantly higher LTP rate of female NLRP3 KO mice with 154.23±7.33% compared to males 
with 127.70±2.98% (p=0.002) (Figure 21A). No differences in the group of littermates were seen 
(Figure 21B). I wanted to know whether littermate female and NLRP3 KO female also differ in 
LTP. Bar graph of the last five minutes of LTP between female littermate and NLRP3 KO mice 
also displays a higher LTP of female NLRP3 KO mice with 154.23±7.33% when compared to LM 
females with 134.14±5.16% (p=0.035) (Figure 21C). No differences could be seen in the 
comparison of male mice of both genotypes (Figure 21D). These findings suggest a sex 
dependent difference with an advantage of knocking out the NALP3 inflammasome in female 
aged mice. 
 
Figure 21 Quantitative analysis of last five minutes of LTP measurements on 24 months old NLRP3 KO mice. Activity-
dependent synaptic plasticity was investigated on acute hippocampal slices of 24 months old littermate control 
female (LM female, light green circles), NLRP3 KO female mice (light red circles) and NLRP3 KO male mice (dark red 
circles) and quantified via analysis of the last 10 minutes of LTP. Field excitatory postsynaptic potentials (fEPSPs) were 
recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. The LTP induction 
rate is shown as percentage % of mean baseline slope. Data points were averaged over 6 time points and error bars 
indicating SEM, n= number of recorded slices/N= number of animals. Data were analyzed by Student´s t-test. (A) Bar 
graph of the last five minutes of LTP show a significantly higher LTP of female NLRP3 KO mice (154.23±7.33) compared 
to males (127.70±2.98) (p=0.002).(B) Bar graph of the LAt five minutes of LTP display no differences between LM male 
and female mice. (C) Bar graph of the last five minutes of LTP between female littermate and NLRP3 KO mice show a 
higher LTP of female NLRP3 KO mice (154.23±7.33) compared to LM females (134.14±5.16) (p=0.035). (D) Bar graph 
of the last five minutes of LTP display no differences between male LM and NLRP3 KO mice. 
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3.2.1.4 Morphological analysis of spine density in 24 months old NLRP3 KO mice 
Morphology was investigated on apical dendrites of hippocampal CA1 neurons stained with the 
Golgi-cox method of 24 months old littermate control and NLRP3 KO mice. Investigations toward 
sex dependent differences were done. Bar graph of spine density displays no differences 
between male NLRP3 KO with 1.38±0.02 spines/µm and female NLRP3 KO mice with 1.34±0.06 
spines/µm (Figure 23A). Quantification of spine density displays no sex dependent differences 
in the group of LM controls. Male have 1.33±0.02 spines/µm and female littermate controls have 
1.41±0.02 spines/µm (Figure 23B). 
 
Figure 22 Morphological analysis of spine density in CA1apical hippocampal region of 24 months old NLRP3 KO 
mice. Morphology was investigated on apical dendrites of hippocampal CA1 neurons stained with the Golgi-cox 
method of 24 months old littermate control and NLRP3 KO mice. Investigations toward sex dependent differences 
were done. Spines at five apical CA1 dendrites at 2nd or 3rd dendritic branches with a length of 100 µm were counted 
per animal. Spine density is shown as number of spines per µm dendrite. Error bars indicating SEM, n= number of 
dendrites/N= number of animals. Bar graph of spine density displays no differences between male NLRP3 KO 
(1.38±0.02) and female NLRP3 KO mice (1.34±0.06). Bar graph of spine density displays no sex dependent differences 
in the group of LM controls (female 1.41±0.03 and male 1.33±0.02). 
In summary, age- and sex-dependent analysis of the NLRP3 KO to LM revealed an increased LTP 
in aged NLRP3 KO female mice compared to age-matched male NLRP3 KO mice as well as 
littermate controls, leading to the speculation of a positive physiological effect of KO the NALP3 
inflammasome within age in a sex dependent manner.  
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3.3 Inflammation caused by autoimmune antibodies 
As Ohkawa et al., could show in 2013 that application of AAB from LGI1 AE patients on 
hippocampal slices interrupted the LGI1-ADAM22 interaction and lead to a decrease in AMPAR 
density and therefore to a decreased synaptic transmission level, I wanted to know, whether 
different AAB samples of patients suffering from AE lead to different electrophysiological and 
morphological outcomes. Therefore, I first checked whether the AAB samples penetrate deep 
enough into the hippocampal slice. 
 
3.3.1 Binding of autoimmune antibodies 
Acute hippocampal slices of Thy-1 GFP mice also used for electrophysiological experiments were 
fixed overnight and used for Immunohistochemistry. Neurons are represented via GFP 
fluorescent signal of the Thy-1 promotor. Blue DAPI signal represents cell bodies by intercalation 
with the DNA. Red signal represents bound IgG. Higher Cy3 fluorescent signal could be seen after 
6 h of AAB incubation only by Patient1 AAB treated slices, therefore more IgG is bound to 
hippocampus, compared to control Patient AAB treatment and ACSF control (Figure 23). 
 
Figure 23 Immunohistochemistry of AAB samples on hippocampal slices. Acute hippocampal slices of Thy-1 GFP 
mice also used for electrophysiological experiments were fixed overnight in 4% PFA and stored into 30% sucrose for 
dehydration. 400 µm transversal hippocampal slices were cutted into 30 µm thick sections before 
Immunohistochemistry. Exposure times of 150 ms for GFP; 4s for human IgG; 3s for GFAP and 50 ms for DAPI. (A) CA1 
hippocampal area of slice treated with AAB of Patient1 for 1 h. (B) CA1 area of slice treated for 6 h with Patient1 
sample. (A’) Serum of healthy control applied on hippocampal slice for 1 h. (B’) 6 h treatment of hippocampal slice 
with serum of control Patient. (A’’) schematic view of area imaged. (B’’) ACSF control treated slice. Scale bar 200 µm. 
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3.3.2 LTP deficits are epitope specific 
As I could be sure, that the AAB of the patients suffering from AE could penetrate into the 
hippocampal slice, I started with electrophysiological measurements. First, I wanted to know 
whether the application of AABs has an effect under basal conditions. Therefore, I started 
baseline recording and applied AAB 10 minutes afterwards and monitored fEPSP for another 30 
minutes of recording. No effects could be seen for AABs from three patients compared to control 
AAB treated slices (Figure 24), described in more detail below.  
 
Figure 24 Basal synaptic recording with AAB application. Field excitatory postsynaptic potentials (fEPSPs) of acute 
hippocampal slices of C57Bl/6-GFP mice treated with control (open circles) or with a-Lgi1-AAB (black circles) of 
Patient1 (upper middle), Patient2 (lower left) or Patient3 (lower right) were recorded in CA1 region by stimulating 
Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. Baseline recording took place for 10 minutes before 
AAB application and another 30 minutes recording. 
Then I started measurements with 1 h incubation time to figure out if differences in synaptic 
transmission are already visible at that very early time point. Furthermore, I also analyzed long-
term application (6 h) as AAB where higher amounts of patient AABs were found compared to 
control treated slices. At first, I analyzed the LTP and basal synaptic transmission parameters of 
hippocampal slices treated with AAB of Patient1 suffering of LE.  
Field excitatory postsynaptic potentials (fEPSPs) of acute hippocampal slices of C57Bl/6-GFP 
mice treated with control (open circles) or with a-Lgi1-AAB of Patient1 (black circles) were 
recorded in CA1 region by stimulating Schaffer collateral axons of area CA3. LTP measurements 
of acute application of AAB of Patient1 reveal no differences in potentiation levels. 
Quantification of the last five minutes of LTP supports the findings. The bar graph displays 
potentiation levels for Patient1 with 134.26±3.92% and for control with 128.06±3.31%. LTP of 
slices continuously perfused for 6 h with AAB of Patient1 show deficits in LTP with 111.67±4.07% 
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compared to slices treated with control serum with 126.29±3.94. Quantification of the last ten 
minutes of long-term application LTP confirms the results (p=0.015) (Figure 25). 
 
Figure 25 LTP measurements on acute hippocampal slices treated with AAB of Patient1. Field excitatory 
postsynaptic potentials (fEPSPs) of acute hippocampal slices of C57Bl/6-GFP mice treated with control (open circles) 
or with a-Lgi1-AAB of Patient1 (black circles) were recorded in CA1 region by stimulating Schaffer collateral axons of 
area CA3 at a frequency of 0.1 Hz. LTP was induced by application of TBS after 10 min baseline stimulation (arrowhead) 
in slices treated for 1 hour (A) with control or a-Lgi1-AAB of Patient1 or for 6 hours (B). The LTP induction rate is shown 
as percentage % of mean baseline slope. (A) During LTP measurement slices were continuously perfused with either 
control or a-Lgi1-AAB of Patient1 but did not show any differences in potentiation levels for acute measurements. 
(A’) Bar graph of the last five minutes of LTP support the findings (Patient1: 134.32±3.92; Control: 128.06±3.31). (B) 
LTP of slices continuously perfused for 6 h with AAB show deficits in LTP. (B’) Bar graph of the last ten minutes of long-
term application LTP confirm the results (Patient1: 111,67±4.07; Control: 126.29±3.94) (p=0.015). 
Input/ Output experiments were performed to check if basal synaptic transmission is intact after 
treatment with AAB of Patient1 for short- and long-term application. Postsynaptic neuronal 
excitability was comparable at all measured stimulus intensities (25-250 µA).  Additionally, PPF 
paradigm analysis was performed to check for intact presynaptic function. Short-term synaptic 
plasticity was intact at all ISI (160 -10 ms). Taken together the results indicate intact pre- and 
postsynaptic function after application of AAB of Patient1 for acute and long-term application 
of AAB (Figure 26).  
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Figure 26 Basal synaptic transmission of Patient1. Field excitatory postsynaptic potentials (fEPSPs) of acute 
hippocampal slices of C57Bl/6-GFP mice treated either with control (open circles) or with a-Lgi1-AAB of Patient1 (black 
circles) were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. 
Input/ Output curves revealed no differences in postsynaptic function after 1 h (A) or after 6 hours (D) treatment of 
acute slices with a-Lgi1-AAB of Patient1. PPF paradigm before (B) first LTP recording revealed no differences in 
presynaptic function after 1 h treatment of acute slices with either control or a-Lgi1-AAB of Patient1. (E) PPF paradigm 
before second LTP recording after 6 h of AAB treatment revealed also no differences. PPF paradigm after (C) first LTP 
recording revealed no differences in presynaptic function after 1 h treatment of acute slices with either control or a-
Lgi1-AAB of Patient1. PPF paradigm after 6 hours of incubation with Patient1 sample after second LTP (F) revealed no 
differences at all. 
As application of samples of Patient1 on acute hippocampal slices lead to normal pre- and 
postsynaptic function but alterations in LTP after long application, I also wanted to know 
whether this is true for samples of other Patients. Therefore, I did the same analysis as before 
with samples of another Patient. Patient1 is suffering from LE, Patient2 in turn is suffering from 
FBDS. 
LTP measurements with sample of Patient2 did not show any differences in potentiation levels 
for acute measurements. Bar graph of the last five minutes of LTP supports the findings. 
Patient2 displays a potentiation level of 118.88±3.35% and control slices show 120.81±3.63%. 
LTP of slices continuously perfused for 6 h with AAB show also no deficits in LTP. As depicted in 
the bar graph of the last five minutes with 118.30±3.92% potentiation for Patient2 and 
115.34±2.75% for control slices (Figure 27). 
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Figure 27 LTP measurements on acute hippocampal slices treated with AAB of Patient2. Field excitatory 
postsynaptic potentials (fEPSPs) of acute hippocampal slices of C57Bl/6-GFP mice treated with control (open circles) 
or with a-Lgi1-AAB of Patient2 (black circles) were recorded in CA1 region by stimulating Schaffer collateral axons of 
area CA3 at a frequency of 0.1 Hz. LTP was induced by application of TBS after 10 min baseline stimulation (arrowhead) 
in slices treated for 1 hour (A) with control or a-Lgi1-AAB of Patient1 or for 6 hours (B). The LTP induction rate is shown 
as percentage % of mean baseline slope. (A) During LTP measurement slices were continuously perfused with either 
control or a-Lgi1-AAB of Patient2 but did not show any differences in potentiation levels for acute measurements. 
(A’) Bar graph of the last five minutes of LTP support the findings (Patient2: 118.88±3.35; Control: 120.81±3.63). (B) 
LTP of slices continuously perfused for 6 h with AAB show also no deficits in LTP. (B’) Bar graph of the last ten minutes 
of long-term application LTP confirm the results (Patient2: 118.30±3.92; Control: 115.34±2.75). 
Additionally, I wanted to check also here for pre- and postsynaptic function. No differences in 
Input/ Output measurements could be seen for acute as well as long-term application of AAB of 
Patient2. I analyzed the PPF paradigm for each condition before and after LTP measurements, 
but I did not record any differences (Figure 28). 
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Figure 28 Basal synaptic transmission of Patient2. Field excitatory postsynaptic potentials (fEPSPs) of acute 
hippocampal slices of C57Bl/6-GFP mice treated either with control (open circles) or with a-Lgi1-AAB of Patient2 (black 
circles) were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. 
Input/ Output curves revealed no differences in postsynaptic function after 1 h (A) or after 6 h (D) treatment of acute 
slices with a-Lgi1-AAB of Patient2. PPF paradigm before (B) first LTP recording revealed no differences in presynaptic 
function after 1 h treatment of acute slices with a-Lgi1-AAB of Patient2. (E) PPF paradigm before second LTP recording 
after 6 h of AAB treatment revealed also no difference at all ISI. PPF paradigm after (C) first LTP recording revealed 
no differences in presynaptic function after 1 h treatment of acute slices with either control or a-Lgi1-AAB of Patient2. 
PPF paradigm after 6 h of incubation with Patient2 sample after second LTP (F) revealed no differences at all. 
To corroborate the results another Patient was analyzed in terms of LTP and basal synaptic 
transmission. Patient3 is suffering from FBDS like Patient2. LTP measurements of acute 
application of Patient3 sample reveal no differences in potential levels compared to control 
treated slices. Quantification of the last five minutes via bar graph supports the findings 
(Patient3: 123.36±3.37%; Control: 124.80±4.80%). LTP of slices continuously perfused for 6 h 
with AAB show also no deficits in LTP. Bar graph of the last five minutes of long-term application 
LTP confirms the results (Patient3: 115.38±2.33%; Control: 115.48±2.45%) (Figure 29). The 
results are comparable with the results of Patient2, but not Patient1 suffering from LE instead 
of FBDS. 
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Figure 29 LTP measurements on acute hippocampal slices treated with AAB of Patient3. Field excitatory 
postsynaptic potentials (fEPSPs) of acute hippocampal slices of C57Bl/6-GFP mice treated with control (open circles) 
or with a-Lgi1-AAB of Patient3 (black circles) were recorded in CA1 region by stimulating Schaffer collateral axons of 
area CA3 at a frequency of 0.1 Hz. LTP was induced by application of TBS after 10 min baseline stimulation (arrowhead) 
in slices treated for 1 h (A) with control or a-Lgi1-AAB of Patient3 or for 6 h (B). The LTP induction rate is shown as 
percentage % of mean baseline slope. (A) During LTP measurement slices were continuously perfused with either 
control or a-Lgi1-AAB of Patient3 but did not show any differences in potentiation levels for acute measurements. 
(A’) Bar graph of the last five minutes of LTP support the findings (Patient3: 123.36±3.37; Control: 124.80±4.80). (B) 
LTP of slices continuously perfused for 6 h with AAB show also no deficits in LTP. (B’) Bar graph of the last ten minutes 
of long-term application LTP confirm the results (Patient3: 115.38±2.33; Control: 115.48±2.45). 
Also, in this stack of experiments, I wanted to check for pre- and postsynaptic function. 
Postsynaptic Input/ Output measurements display no differences for acute as well as long-term 
application of AAB of Patient3. PPF before first LTP recording revealed no differences in 
presynaptic function after 1 h treatment of acute slices with either control or a-Lgi1-AAB of 
Patient3. PPF paradigm before second LTP recording after 6 h of AAB treatment instead reveals 
differences at an ISI of 10 ms. Slices treated with control AABs reveals a higher ratio of slope1 to 
slope2 which could be due to a higher vesicle recycling in the presynapse. As control AABs of 
other patients do not show this shape of curve it maybe an artifact. PPF paradigm after first LTP 
recording revealed no differences in presynaptic function after 1 h treatment of acute slices with 
either control or a-Lgi1-AAB of Patient3. PPF paradigm after 6 h of Patient3 sample incubation 
after second LTP revealed also no differences (Figure 30). 
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Figure 30 Basal synaptic transmission of Patient3 Field excitatory postsynaptic potentials (fEPSPs) of acute 
hippocampal slices of C57Bl/6-GFP mice treated either with control (open circles) or with a-Lgi1-AAB of Patient3 (black 
circles) were recorded in CA1 region by stimulating Schaffer collateral axons of area CA3 at a frequency of 0.1 Hz. 
Input/ Output curves revealed no differences in postsynaptic function after 1 h (A) or after 6 h (D) treatment of acute 
slices with a-Lgi1-AAB of Patient3. PPF paradigm before (B) first LTP recording revealed no differences in presynaptic 
function after 1 h treatment of acute slices with either control or a-Lgi1-AAB of Patient3. (E) PPF paradigm before 
second LTP recording after 6 h of AAB treatment reveals differences at ISI 10 ms. Slices treated with control reveals a 
higher ratio of slope1 to slope 2 which could maybe due to a higher vesicle recycling in the presynapse. PPF paradigm 
after (C) first LTP recording revealed no differences in presynaptic function after 1 h treatment of acute slices with 
either control or a-Lgi1-AAB of Patient3. PPF paradigm after 6 h of Patient3 sample incubation after second LTP (F) 
revealed also no differences.  
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3.3.3 Morphological changes in spine density after AAB application 
As electrophysiological recordings reveal changes in LTP after long-term application of AAB of 
Patient1 but not Patient2 or 3, I wanted to check whether these findings could be substantiated 
with morphological alterations. Therefore, I analyzed the spine density in pyramidal cells of CA1 
apical region as well as dentate gyrus granule cells.  
Spine density of apical CA1 pyramidal cell dendrites after acute application of Patient1 on BL6 
acute hippocampal slices reveals no differences with 1.91±0.05 spines/µm compared to slices 
treated with control serum with 1.95±0.05 spines/µm (Figure 31A). Similar results were 
obtained after long application of AAB of Patient1 with 1.84±0.04 spines/µm compared to 
control serum treated slices with 1.78±0.04 spines/µm (Figure 31B). Spine density of DG granule 
cell dendrites after long application of Patient1 on BL6 acute hippocampal slices in turn is 
decreased with 1.73±0.05 spines/µm compared to slices treated with control serum with 1.89± 
0.03 spines/µm (p=0.014) (Figure 31C).  
With regard to Patient2, spine density of apical CA1 displays no differences with 2.04±0.06 
spines/µm compared to control 1.96±0.06 spines/µm (Figure 31A’). CA1 apical spine density 
after 6 h application of AAB of Patient2 reveals also no differences with 2.00±0.03 spines/µm 
compared to slices treated with control serum with 1.96±0.04 spines/µm (Figure 31B’). Dentate 
gyrus spines density after long application of Patient2 also reveals no differences with 2.23±0.07 
spines/µm compared to control slices with 2.19±0.07 spines/µm (Figure 31C’).  
After acute application of Patient3 AABs on BL6 acute hippocampal slices, spine density of apical 
CA1 pyramidal cell dendrites reveals no differences with 1.86±0.04 spines/µm compared to 
slices treated with control serum with 1.87±0.03 spines/µm (Figure 31A’’). Same is true for spine 
density of apical CA1 dendrites after long application of AAB of Patient3 on BL6 acute 
hippocampal slices with 1.80±0.04 spines/µm compared to control serum treated slices with 
1.87±0.03 spines/µm (Figure 31B’’). Spine density of DG granule cell dendrites after long 
application of Patient3 also reveals no differences with 2.00±0.05 spines/µm compared to 
control with 1.96±0.06 spines/µm (Figure 31C’’).  
Together these data reflect the electrophysiological measurements, where only long-term 
application of AAB of Patient1 was leading to alterations in LTP curve. 
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Figure 31 Analysis of spine density in CA1 apical and DG hippocampal region of all 3 Patients after 1 h and 6 h 
application of AAB. (A) Spine density of apical CA1 pyramidal cell dendrites after acute application of Patient1 on BL6 
acute hippocampal slices reveals no differences (1.91±0.05) compared to slices treated with control serum 
(1.95±0.05). (B) Spine density of apical CA1 dendrites after along application of AAB of Patient1 on BL6 acute 
hippocampal slices (1.84±0.04) reveals also no differences compared to slices treated with control serum (1.78±0.04). 
(C) Spine density of DG granule cell dendrites after long application of Patient1 on BL6 acute hippocampal slices 
(1.73±0.05) is decreased compared to slices treated with control serum (1.89± 0.03) (p=0.014). (A’) Spine density of 
apical CA1 pyramidal cell dendrites after acute application of Patient2 on BL6 acute hippocampal slices (2.04±0.06) 
reveals no differences compared to slices treated with control serum (1.96±0.06). (B’) Spine density of apical CA1 
dendrites after along application of AAB of Patient2 on BL6 acute hippocampal slices (2.00±0.03) reveals also no 
differences compared to slices treated with control serum (1.96±0.04). (C’) Spine density of DG granule cell dendrites 
after long application of Patient2 on BL6 acute hippocampal slices (2.23±0.07) reveals no differences compared to 
slices treated with control serum (2.19±0.07). (A’’) Spine density of apical CA1 pyramidal cell dendrites after acute 
application of Patient3 on BL6 acute hippocampal slices (1.86±0.04) reveals no differences compared to slices treated 
with control serum (1.87±0.03). (B’’) Spine density of apical CA1 dendrites after along application of AAB of Patient3 
on BL6 acute hippocampal slices (1.80±0.04) reveals also no differences compared to slices treated with control serum 
(1.87±0.03). (C’’) Spine density of DG granule cell dendrites after long application of patien3 on BL6 acute hippocampal 
slices (2.00±0.05) reveals no differences compared to slices treated with control serum (1.96±0.06). Data presented 
as mean ± SEM, n = number of dendrites, N= number of animals, spines=number of total spines. Scale bar of confocal 
images 5 μm.
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4. Discussion 
Synaptic plasticity is one of the most important mechanisms of the brain to build memories. 
Thereby, strengthening and weakening of a synapse occur upon activity for example in case of 
LTP or LTD. In many diseases these mechanisms are disrupted but can be rescued via the 
application of molecules acting positively in physiological situations or via the knockout of 
special genes. This study can be divided into three parts where I analyzed synaptic plasticity at 
hippocampal CA1-CA3 synaptic pathway in order to investigate: 1. Alzheimer’s disease, normally 
occurring later in lifespan; 2. Physiological aging with respect to inflammation and 3. An 
autoimmune disease that is more likely to occur early in life. I also looked for potential rescue 
molecules or mechanisms in the respective disease. One potential rescue molecule could be 
APPsα, as previous studies could show a positive effect on synapses (Hick et al., 2015; Ishida et 
al., 1997; Tyan et al., 2012, Fol et al., 2016). And indeed, I also could find out that recAPPsα is 
able to stabilize LTP in NexCre cDKO mice and additionally I could show that recAPPsα is acting 
via the α7-nAChR, which was unclear until then (3.1.1 Inhibition of α7-nAChR by BTX blocks 
positive effects of recAPPsα on LTP). Furthermore, I determined that recAPPsα is able to stabilize 
LTP in aged hatu.P301S mice that display a tau-tangle phenotype like in Alzheimer’s disease 
(3.1.2.1 Increased LTP of aged htau mice rescued via application of recAPPsα). But I did not only 
look for APPsα, a cleavage product of the non-amyloidogenic pathway but also for Aηα, a small 
peptide from the η-secretase pathway and recorded contrary results compared to APPsα (3.1.3 
Injection of Aηα show no effect on hippocampal synaptic plasticity). Another potential rescue 
mechanism I investigated during my thesis is the KO of the NALP3 inflammasome. The study of 
Heneka et al. (2013) could show a positive effect of knocking out the NALP3 inflammasome in 
APP KO mice. Therefore, I wanted to know whether this result is also true for physiological aging. 
Indeed, I could see positive effects that are additionally sex dependent (3.2.1 Sex dependent 
differences occur during aging). The last part of my thesis deals with human autoimmune 
antibodies and its functions on activity dependent synaptic plasticity in the murine 
hippocampus. In my thesis, I was able to show that long-term application of AAB of different 
patients leads to epitope dependent changes in LTP and spine density in acute hippocampal 
slices (3.3 Inflammation caused by autoimmune antibodies). 
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4.1 APPsα and Aηα as potential rescue molecules in Alzheimer’s disease 
In the first part of my thesis, I looked for different cleavage products of the APP family to have 
positive functions on synaptic plasticity. Therefore, I analyzed the effect of APPsα, a cleavage 
product of the non-amyloidogenic pathway, on the LTP of NexCre cDKO mice 
(NexCre+/TAPPflox/floxAPLP2flox/floxAPLP1-/-). Additionally, I looked for BTX in these experiments 
acting via the alpha7 nicotinic acetylcholine receptor (α7-nAChR). Furthermore, I checked for 
APPsα as a potential rescue molecule for altered plasticity in htau.P301S mice, representing tau 
tangles in the brain like in Alzheimer’s disease. Furthermore, I looked for the function with 
respect to synaptic plasticity of another cleavage product of APP in the η-secretase pathway: 
Aηα. The main finding regarding the cleavage products of APP showed that there are differences 
in the effect of APPsα and Aηα on acute hippocampal slices with respect to electrophysiological 
measurements, described in more detail below. 
 
4.1.1 APPsα in NexCre cDKO mice 
As a recent study (Hick et al.,2015) could show a rescued LTP curve in NexCre cDKO mice after 
the application of recAPPsα, I intend to get information about the referring receptor. Under the 
control of the NEX promotor the ablation of APP is triggered at embryonic day 11.5 in mice with 
an APLP2 deficient background. Hick et al., could also show that APPsα is able to rescue LTP 
deficits in NexCre cDKO by acute application of APPsα on hippocampal slices. Another study of 
Taylor et al. (2008) pointed out that infusion of recAPPsα into the dentate gyrus (DG) of rats 
enhances DG-PP LTP in vivo. These results were matching to the study of Moreno et al., (2015) 
reporting that recAPPsα is able to rescue LTP deficits in an age-dependent manner in vitro. 
Regarding the results, I assume that APPsα acts positively on LTP deficits in hippocampal region, 
but the receptor is still unknown. A previous study could show, that alpha7 nicotinic 
acetylcholine receptor (α7-nAChR) seems to be a target to rescue deficits in hippocampal LTP in 
Aβ infused rats (Chen et al., 2006). The α7-nAChR seems to play a big role in AD. As it is mainly 
located in neurons of the basal forebrain which projects to the hippocampus and cortex, the 
brain areas exhibiting severe plaque pathology in AD (Wang et al., 2000). In this regard the α7-
nAChR might be not only a target for APPsβ  but also for APPsα. Acute slices of NexCre cDKO 
mice treated with 10 nM recAPPsα or 10 nM recAPPsα with wash in of 10 nM BTX, a ligand of 
the respective receptor, 10 minutes before starting baseline recording display an 
indistinguishable LTP curve in induction and maintenance whereas the application of BTX 
together with APPsα on the other hand lead to a reduction of LTP induction and maintenance 
(3.1.1 Inhibition of α7-nAChR by BTX blocks positive effects of recAPPsα on LTP). This result leads 
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to the suggestion that on the one hand APPsα is acting via the α7-nAChR because in its presence 
and the absence of BTX, LTP was enhanced. On the other hand, BTX only binds to the α7-nACh 
receptor in the absence of APPsα and therefore seems to be its antagonist.   
 
4.1.2 APPsα in htau.P301S mice 
APPsα is known to have various positive effects on synaptic plasticity (Corrigan et al., 2012; Ring 
et al., 2007, Weyer et al., 2011), therefore it was used in this part of my study to rescue the 
imbalance in LTP in aged hTau.P301S mice. This transgenic mouse model expresses MAPT with 
a P301S mutation. This tauopathy model is associated with autosomal-dominant disease in 
humans and shows several molecular, cellular, and behavioral features of human tauopathy, 
including tau hyperphosphorylation, tau filament formation, neurodegeneration, and motor 
impairment. The mice exhibit widespread tau pathology, affecting the cerebral cortex, 
hippocampus, brain stem, and spinal cord. In the spinal cord, tau pathology leads to a 
progressive loss of motor neurons up to approximately 50 %, and severe motor impairment 
(Allen et al., 2002). At the age of 10-13 weeks there is an initial phenotype of htau.P301S. A 
reduced spine density and first effects of cognitive decline are specific markers at this time point. 
The results of electrophysiological measurements show a significantly lower LTP in induction 
phase, which is not stable until the maintenance phase of LTP measurements. Also, Boeckhoorn 
and colleagues could show in 2006 a trend of decreased LTP in CA1 hippocampal region in young 
transgenic tau P301S mice compared to wildtype mice. Maybe the initial spine loss seen in 
literature is leading to a decreased induction phase of LTP that can be compensated through 
existing physiological spines leading to a stable LTP in maintenance. As there was significantly 
decreased induction phase of LTP in young htau.P301S mice, measurements with older 
htau.P301S mice were performed to analyze the advanced phenotype. 
At the time point of 16-18 weeks, the phenotype of htau.P301S mice is characterized by tangles 
in the cortex and hippocampus and a progressive spine loss. In the hippocampus, a decrease in 
spine density and spine length has been observed starting at 2.5 months of age (Xu et al., 2014). 
At the age of 20 weeks, weight loss and severe motor deficits upon progressive loss of motor 
neurons up to 50 %, displayed by paralysis of hind feet, are observed. Astro- and microgliosis 
are one of the main inflammatory processes observed at this stage. The results of LTP 
measurements in acute hippocampal slices display a significant higher LTP curve in htau.P301S 
mice. The results of Boeckhoorn and colleagues 2006 also proves an increase of LTP even before 
onset of hyperphosphorylation and tauopathy in DG granule cells of 8-10 weeks old transgenic 
tau P301S mice compared to wildtype. This result maybe a hint towards altered LTP also in other 
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regions in a progressed aging time point due to progressive spine loss from DG towards CA3 and 
CA3 hippocampal region. Not only a decrease in LTP could be a result of spine loss but also 
hyperexcitation could be a sign of altered synaptic plasticity. Oligomeric protein assemblies have 
been shown to bind and activate a variety of pattern recognition receptors (PRRs) (Komic et al., 
2018), thus activating microglia cells as well as astrocytes. As brain homeostasis is altered in 
htau.P301S mice models upon microgliosis and astrogliosis (Allen et al., 2002), remaining spines 
could be hyperactivated during LTP, resulting in increased vesicle release or increased receptor 
incorporation into the membrane to compensate progressive spine loss. This hypothesis is in 
line with the PPF data, representing a higher PPF in htau.P301S mice and an even higher LTP in 
APPsα treated transgenic mice. The theory of altered presynaptic vesicle release rescued via 
APPsα application can be based on studies showing that APP is localized at the presynaptic active 
zone (Lassek et al., 2013, Wilhelm et al., 2014). Also the EPSP data, representing the postsynaptic 
part, could reflect the assumption of a spine loss in htau.P301S mice. EPSP curve of transgenic 
mice is significantly decreased reflecting a decreased number or a reduced function of spines. 
With the application of 10 nM recAPPsα the imbalance in homeostasis is rescued.  
 
4.1.3 Function of Aηα 
In my electrophysiological experiments the hypothesis of Willem et al. could not be confirmed. 
In the study of Willem et al. (2015) they could show, that pharmacological BACE1 inhibition with 
oral dose of 100 mg/kg SCH1682496 lowers hippocampal LTP. Additionally, Aηα but not Aηβ 
conditioned media from untransfected cells or artificial cerebrospinal fluid significantly inhibited 
LTP. In my study a vector was chosen for injection of Aηα into hippocampal region. Therefore, 
differences in the outcome of my study and the study of Willem et al. could be due to other 
components of the media, missing in my experiments. Furthermore, the stimulating protocol 
was different. Willem and colleagues used a high-frequency stimulation protocol with 10 trains 
of 10 pulses at 100 Hz applied, with 2-s inter-train intervals. I used a TBS stimulating protocol 
that consist 10 trains of 4 pulses at 100 Hz in a 200 ms interval, repeated 3 times (see Figure 10). 
Also, the injection of Aηα could lead to inevitable neuronal damage, which putatively influence 
the experiments. Aηα injection was performed in Heidelberg in the lab of U. Müller. WtR6 
littermate controls were injected with an empty vector only containing Venus (pAAVss-Syn-
lckVenus(1x10e9)) whereas Aηα injection was performed with two different titer pAAVss-Syn-
lckVenus-T2A-Aη-α(1*10e9) and pAAVss-Syn-lckVenus-T2A-Aη-α(1*10e10). They could prove, 
that 3 weeks after injection pyramidal cell layer of CA1-CA3 hippocampal neurons was intact 
and as control injection of WT animals with inactivated vector lead to physiological LTP this 
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theory of neuronal damage due to injection could be disposed. Another theory could be based 
on the low titer. This theory is supported by the fact that there are no visible differences in 
electrophysiological measurements for both titers. In Heidelberg they were able to tag the 
pAAVss-Syn-lckVenus-T2A-Aη-α via human specific antibody (6E10) and it was expressed widely 
in hippocampal region. Also, the microscopically search for fluorescent light, representing the 
expression of the vector through the yellow fluorescent protein Venus, in the hippocampal 
region directly before measurements was positive. The AAV-vectors contained the synapsin 
promotor, therefore expression of the encoded fluorescent protein Venus was linked to 
neurons. Therefore, one can be sure that Aηα was expressed in the region of interest but maybe 
not high enough. The titer of 109 and 1010 was as high or even higher as the titer used for APPsα 
experiments, because of the comparability of these experiments the titer was chosen. To 
manifest this hypothesis, the experiments need to be repeated with a higher, but still 
physiological titer of Aηα. 
 
4.1.4 APPsα vs other cleavage products  
There are various cleavage products from the APP family with various functions. APPsα a 
cleavage product from the non-amyloidogenic pathway has been proven to act neuroprotective 
(Turner et al., 2003; Copanaki et al., 2010) whereas peptides from the amyloidogenic pathway 
have neurodegenerative functions. Amyloid β for example as well as tau protein have well 
established roles in Alzheimer’s disease. In postmortem AD brains they are visible as amyloid 
plaques and neurofibrillary tangles (NFTs), the two hallmarks of AD (Shipton et al., 2011). First, 
at picomolar concentrations Aβ was shown to be essential for synaptic plasticity by modulating 
synaptic vesicle release (Abramov et al., 2009, Wang et al., 2012) leading to enhanced LTP (Puzzo 
et al., 2008). Second, acute application of natural or synthetic Aβ has been proven to impair 
hippocampal LTP when used in nanomolar concentrations (Cullen et al., 1997; Lambert et al., 
1998) and NFTs are elevated in the hippocampal CA1 area and correlate with memory decline 
(Markesbery et al., 2006). APPsβ, another fragment from the amyloidogenic pathway that is 
identical in primary sequence except for the last 16 amino acids compared to APPsα, failed to 
show any detectable effects on synaptic plasticity and spine density (Richter et al., 2018). One 
could have thought about a nearly identical or even similar function of APPsβ, but it seems like 
only the last 16 amino acids (CTα16) have a positive function in the brain. This theory has been 
proven by Richter and colleagues where they could show that LTP deficits of conditional CNS 
specific APP/APLP2 double knockout mice (Hick et al., 2015) are rescued by application of CTα16 
to the same extend as APPsα (Richter et al., 2018). APPsα seems to be a potential rescue 
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molecule in terms of Alzheimer’s disease with its various positive functions for example 
neuroprotection or spine formation (Barger and Harmond 1997; Turner et al., 2003; Copanaki 
et al., 2010; Richter et al., 2018). Furthermore, APPsα is able to act on disease associated 
alterations like extensive NMDA receptor activation (Ryan et al., 2013) as well as acting positive 
on Aβ toxicity (Barger and Mattson, 1996). Additionally, reduced levels of sAPPα could 
contribute to neuronal degeneration in AD as well (Furukawa et al., 1996). As Aηα is a short 
sequence from APPsα (Figure 2) one could assume, that it has a comparable function. CTFs 
(carboxy-terminal fragments) produced by η-secretase are enriched in dystrophic neurites in an 
AD mouse model as well as in human AD brains. Furthermore, they could show that in mice 
treated with a potent BACE1 inhibitor, the secretase leading to Aηα formation, hippocampal LTP 
was reduced. Moreover, when recombinant or synthetic Aη-α was applied on hippocampal 
slices ex vivo, LTP was lowered (Willem et al., 2015). This is not adaptable for Aηβ. LTP was 
unaffected when Aηβ was applied. Nevertheless, in my study Aηα seems to have no influence 
on acute hippocampal slices when used in the same concentration as APPsα.   
 
4.2 NALP3 in physiological aging 
The second part of my study contains the knockout (KO) of the NALP3 inflammasome and its 
effects on physiological aging. As also inflammatory processes play an important role in the 
progress of neurodegenerative diseases like AD, special attention was given to this part of my 
thesis. Aβ activation of the NALP3 inflammasome in microglia is fundamental for interleukin-1β 
(IL-1ß) maturation, a pro-inflammatory cytokine, promoting inflammatory processes (Halle et 
al., 2008). IL-1ß is a molecule shown to limit adult neurogenesis and recovery of presynaptic 
termini (Garber et al., 2018), a mechanism essential for hippocampal recovery in 
neurodegenerative diseases as well as physiological aging. Also, Heneka et al. (2013) could show 
that KO of NLRP3 is beneficial regarding impaired spatial memory and reduced brain caspase-1 
and IL-1β activation. Additionally, they showed an enhanced Aβ clearance (Heneka et al., 2013). 
Therefore, a positive effect of the KO of the NALP3 inflammasome is assumed regrading 
physiological aging.  
 
4.2.1 Sex dependent differences in the brain 
The sex dependent analysis showed that in aged NLRP3 KO female mice increased LTP compared 
to age matched male NLRP3 KO mice as well as littermate controls are detected, leading to the 
speculation of a positive physiological effect of KO the NALP3 inflammasome within age in a sex 
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dependent manner. There are various studies dealing with the question about sex dependent 
differences in the brain that are linked to numerous of diseases (Whitacre 2011; Lenz et al., 
2013; Lenz and McCarthy 2014; Schwarz and Bilbo, 2018; Liu et al., 2019). One could assume 
that males are more likely to be diagnosed with disorders that have distinct developmental 
origins such as autism or schizophrenia (Werling und Geschwind 2013). Compared to that, 
females are more likely to be diagnosed with disorders that occur later in life like depression 
and anxiety disorders (Schwarz and Bilbo, 2018). The study of Lenz and McCarthy (2014) 
reported a differentially regulated inflammatory system in male and female brain, depending on 
the number of microglial cells. Another study of Lenz proved that immune cells in the brain 
interact with the nervous systems during development and that they are crucial for sexual 
differentiation of brain and behavior (Lenz et al., 2013). Another recent study pointed out that 
female microglia phagocytize more neural progenitor cells and healthy cells compared to males 
and that females also have higher expression of several phagocytic pathway genes in the 
hippocampus compared to males (Nelson et al., 2017). Also, the number and morphology of 
microglia throughout development is dependent upon the sex and age. Males have more 
microglia early in postnatal development whereas females have more microglia with an 
activated morphology later in development (Schwarz et al., 2011). As the number of activated 
microglia is enhanced with age in female one could claim, that KO of the NALP3 inflammasome 
located in microglia cells and responsible for cytokine release is leading to an improved 
phenotype as seen in my study. The study of Liu et al (2019) could show that female mice are 
more sensitive to chronic unpredictable mild stress and this is leading to the activation of 
microglia in a sex dependent manner. This discovery suggested that females were inclined to 
have more pro-inflammatory cytokines after stress. Lenz and McCarthy (2014) cleared out that 
in the developing rodent brain across during the neonatal period males have more microglia 
cells than females that releases prostaglandins which are essential contributors to the induction 
and maintenance of dendritic spine excitatory synapses in the developing male brain. 
Additionally, they could show, that the expressions of BDNF and its receptor TrkB is decreased 
in a more pronounced way in the hippocampus in female compared to male mice due to stress. 
As BDNF is crucial for development of new connections, restoration of failing brain cells and 
protection of healthy brain cells, this could lead to a disadvantage in the female brain. 
Furthermore, they could also show a sex-specific relationship between BDNF and hippocampal 
microglia-related inflammatory biomarkers. The study speculated that the imbalance of 
microglial pro- and anti-inflammatory states as well as the BDNF-TrkB-dependent pathway in 
hippocampus is involved in depressive-like behaviors (Liu et al., 2019). Overall, there is evidence 
for sex dependent differences in the brain. 
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4.3 Autoimmune antibodies 
The last part of my thesis deals with an autoimmune disease triggered by autoimmune 
antibodies. The clinical significance and spectrum of AE is rapidly expanding after the initial 
discovery of the two most prevalent types of AE, namely, anti–leucine-rich glioma-inactivated 1 
(anti-LGI1) and anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis (Kim et al., 2017; 
Dalmau et al., 2008; Lai et al., 2010; Irani et al., 2010). A study of Planagumà and colleagues in 
2015 could show that autoimmune antibodies could alter the function of NMDAR resulting in 
memory and behavior alterations. Another study of Hughes et al., 2010 could show that these 
alterations occur without effecting number of spines, dendritic complexity, localization or 
expression of other synaptic proteins as well as cell survival. Lalic et al., could show in 2011 that 
LE IgG increases the release probability on MF-CA3 pyramidal cell synapses compared to the 
control IgG. In my study I could show a decreased LTP in CA1/CA3 hippocampal area as well as 
decreased spine density in DG granule cells after long-term application of AAB of Patient1. As 
only Patient1 is showing an altered LTP and IgG4 subclass was present as in others but IgG1 
subclass was absent one could assume, that the binding of LGI-1 AAB is epitope dependent. 
Therefore, the binding site of LGI-1 needs to be clarified. Lovero et al. (2015) could show that 
leucine-rich, glioma inactivated protein 1 (LGI1) is a paracrine signal released from pre- and 
postsynaptic neurons that acts specifically through a disintegrin and metalloproteinase protein 
22 (ADAM22) to set postsynaptic strength. If the interaction of ADAM22 and LGI-1 is altered 
through AAB, postsynaptic strength is decreased; resulting impaired LTP buildup. This result fits 
with Patient1 as LTP is decreased after long application of AAB on acute hippocampal slices. 
Other studies additionally showed that IgG4 subclass AAB alters neuronal function through a 
disruption of LGI-1 and ADAM22 which is leading to a secondary dysregulation of synaptic 
receptors and therefore altered synaptic transmission (Niks et al., 2008; Arino et al., 2006). 
Another study that deals with NMDAR-AAB could show that patients AAB increase the rate of 
internalization in a time and activity dependent manner. After 4 h no significant differences 
where seen while after 12 h the internalization rate of NMDAR was significantly enhanced in 
Patient’s antibody treated hippocampal neurons (Moskato et al., 2016). Same is true for 
experiments performed in this study. After short-term application of AAB of Patient1 on acute 
hippocampal slices no differences in LTP was recorded but after long-term application of 6 h, 
decreased LTP was seen. As basal synaptic transmission is unaffected, one could assume a 
NMDAR dependent mechanism. As PPF overall is not altered, the presynaptic part seems to be 
unaffected. 
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Nevertheless, Figure 32 shows possible binding sites of autoimmune antibodies on LGI1. In the 
left upper panel (healthy) the LGI1 protein interacts with its EPTP domain (blue) with the 
ADAM22 receptor postsynaptically and with the ADAM23 receptor presynaptically (red). LGI1 
also interacts with other LGI1 proteins via binding of the LRR domain (green) to the EPTP domain. 
In Patient1 (upper right panel) the LRR domain interaction is blocked due to AAB binding, only 
the EPTP domain can interact with ADAM22/23. Therefore, pre- and post-synaptic interaction is 
disturbed. The binding site of AABs in Patient1 is LGI-1. In the lower left panel, the AAB is binding 
to the EPTP domain and therefore the binding of LGI1 to its receptors ADAM22/23 is blocked. 
Autointeraction of LGI1 is still possible and this was seen in Patient2. In Patient3 the AAB bind 
also on EPTP domain and therefore prevent binding of LGI1 to ADAM22/23 just as with Patient 
2. Additionally, the AAB binds to the LRR domain but in a way the LRR/EPTP still remains possible. 
Taken together, AABs of Patient1 interact with LGI-1 whereas in Patient2 and 3 the interaction 
takes place with ADAM22. This result is reflected in the LTP data, where only alterations could 
be seen by Patient1. Therefore, the interaction of the EPTP domain with the LRR domain seems 
to be crucial for the maintenance of LTP. 
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Figure 32 Patients brain and IgG epitopes. (A) Serial MRI sections regarding the hippocampus. Patient1 developed a 
hippocampal sclerosis. Patient2 and 3 did not. (B)  Dot blot analysis splitting up the IgG fraction of the three patients 
into IgG subclasses; (C) schematic presentation of the data of the epitope mapping which show the binding of the 
anti-LGI1 abs of the respective patients to the LGI1 molecule according to Yamagata and coworker (Yamagata et al., 
2018). Ab binding to epitopes with the highest affinity is marked with a Y, respectively. In the healthy control the LGI1 
protein interact with its EPTP domain (blue) with the ADAM22 receptor postsynaptically and with the ADAM23 
receptor presynaptically (red). It also interacts with other LGI1 proteins via binding of the LRR domain (green) to the 
EPTP domain. In Patient1 the LRR domain interaction is blocked due to AAB binding, only the EPTP domain can interact 
with Adam22/23. In the lower left panel (Patient2) the AAB is binding to the EPTP domain and therefore the binding 
of LGI1 to its receptors ADAM22/23 is blocked. Autointeraction of LGI1 is still possible. In Patient3 the AAB bind also 
on EPTP domain and therefore prevent binding of LGI1 to ADAM22/23 just as with Patient2. Additionally, the AAB 
bind to the LRR domain but in a way the LRR/EPTP still remains possible. HLA=human Leukocyte Antigens, HLA-
DR/DQ/DP=cell surface receptor proteins on antigen presenting cells (MHC subclass II).  
This result suggests that epitope specific binding of AABs lead to different clinical outcomes 
represented in distinct LTP levels as well as spine density differences in different hippocampal 
regions.
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5. Conclusion and Outlook 
In my thesis, I could show various functions of different molecules regarding synaptic plasticity 
under the aspect of aging and gender. On the one hand APPsα, a cleavage product from the APP 
family via the non-amyloidogenic pathway has a positive effect on LTP in APP/APLP2 cDKO mice 
acting via the α7-nAChR. Additionally, in aged, but not young htau.P301S mice representing tau 
tangles in the hippocampus, like in Alzheimer’s disease, application of recAPPsα is leading to a 
rescued LTP as well as EPSP towards WT level, whereas LTD and presynaptic function seems to 
be uneffected. One need to have a look into the exact mechanism of the recaps acting on the 
α7-nAChR. On the other hand, the application of Aηα, another cleavage product from the APP 
family via the η-secretase, shows no effect on electrophysiological measurements. As other 
studies reported a negative function of Aηα on LTP one need to administrate the titer of Aηα to 
ensure using the right concentration. 
Another finding indicates a sex dependent positive effect of the KO of the NLRP3-Inflassamome 
in aged mice. With age the inflammation system in the brain is susceptible for interferences, 
which in some case is leading to hyperactivation and damage of neurons. Whereas in young 
mice the KO of the NALP3 inflammasome seems to have no influence on the synaptic plasticity 
in the murine hippocampus, in aged female mice the KO of the NALP3 inflammasome has an 
advantage towards an increased LTP compared to male mice as well as age and sex matched 
littermate controls. To define the exact time point when the positive effect of KO the NALP3 
inflammasome occurs, experiments need to be done on more aging time points between 12 and 
24 months. One could also have a look for other inflammasomes like the NLRP1 inflammasome 
mainly found in neurons to have a positive effect on synaptic plasticity during aging processes. 
Furthermore, there is need for further investigation on the exact mechanism, why females show 
an enhanced LTP whereas males do not. Therefore, one could have a look for sex dependent 
function of distinct molecules like IL-1β released via the NLRP3 inflammasome in aged WT 
animals.  
The last part of my thesis deals with autoimmune antibodies, where I confirmed that long-term 
but not acute application of human AAB on acute hippocampal slices is leading to a reduced LTP, 
which is additionally epitope dependent. To verify the epitope dependent effect of AAB on long-
term application as well as morphological changes, more patients suffering from the same type 
of autoimmune disease like Patient1 need to be included in the study. Furthermore, the 
application time of ABB or the concentration need to be changed to have a closer look into 
incubation time and acute functions of AAB. One also needs to identify the mechanism of spine 
density alteration in the hippocampus after long-term application of AAB of Patient1.
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Abbreviations 
(f)EPSP 
EC 
(field) excitatory postsynaptic potential 
enthorinal cortex 
(α)BTX α-Bungerotoxin 
°C grad Celsius 
µm micrometer 
AAB autoimmune antibody 
ACSF artificial cerebrospinal fluid 
ADAM α-disintegrin and metalloproteinase 
AE autoimmune mediated encephalitis 
AMPA 
α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid 
APLP1 and 2 amyloid precursor-like protein 1 and 2 
APP amyloid precursor protein 
APPsα 
secreted Amyloid precursor protein 
ectodomain after α-secretase cleavage 
APPsβ amyloid precursor protein 
ASC 
secreted Amyloid precursor protein 
ectodomain after β-secretase cleavage 
Aβ amyloid-β 
BACE-1 β-site APP cleaving enzyme 
BDNF brain derived neurotrophic factor 
CA cornu Ammonis 
CARD 
CASP1 
caspase recruitment domain 
caspase-1 
CERAD 
consortium to establish a registry for 
Alzheimer's Disease 
CTF-η carboxy terminal fragment η 
DAMP damage associated molecular pattern 
DG dentate gyrus 
E-LTP early LTP 
EPTP epitempin 
FAD familiar form of Alzheimer’s disease 
FBDS fraciobrachial dystonic seizures 
FV fiber Volley 
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g gram 
GR glucocorticoid receptor 
h hour 
HLA human leukocyte antigens 
HLA-DR/DP/DQ 
cell surface receptor proteins on antigen 
presenting cells (MHC class II) 
IL interleukin 
ISI inter stimulus interval 
L liter 
LE limbic encephalitis 
LGI1 leucin rich glioma inactivated protein 1 
L-LTP late LTP 
LM littermate 
LRR leucin rich repeat 
LTD long-term depression 
LTP long-term potentiation 
M mol 
min minute 
MRI magnetic resonance imaging 
ms millisecond 
mV millivolt 
NALP3/ NLRP3 
NOD („nucleotide-binding oligomerization 
domain“)-, LRR („leucin rich repeat“- und 
„pyrin domain-containing 3“) protein 
NFT neurofibrillary tangle 
Nfκb 
nuclear factor 'kappa-light-chain-enhancer' of 
activated B-cells 
nM nano molar 
NMDA N-Methyl-D-Aspartat 
NOD nucleotide-binding oligomerization domain 
ns not significant 
OHC organotypic hippocampal cultures 
PB phosphate buffer 
PBS phosphate buffered saline 
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PKA 
cyclic adeonosine 3’,5’-monophosphate 
(cAMP)–proteinkinase 
PKC proteinkinase C 
PPD paired pulse depression 
PPF paired pulse facilitation 
PRR pattern recognition receptor 
PS (1 or2) presenilin (1 or 2) 
PSD post synaptic Density 
PTP post tetanic potentiation 
ROI region of interest 
RRP ready releasable pool 
RT room temperature 
SEM standard deviation  
STP short-term plasticity 
TBS theta burst stimulation 
TLR toll-like receptor 
WT wildtype 
ZNS central nervous system 
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